��ѻ��ý

Highlights of MMI Faculty Quoted in the Media 

2025
 

June 8, 2025 
The Hill

Professor Nicole Baumgarth , director of the Lyme and Tickborne Diseases Research and Education Institute (LTDBI) shares insights on emerging tickborne diseases including babesiosis, Heartland virus, Powassan virus, and alpha-gal symdrome. 

June 5, 2025
Local10 ABC (Florida)

MMI and JHMRI Associate Professor Conor McMeniman provides tips on how to protect our homes and family from mosquitoes. 

June 3, 2025
AccuWeather

Assistant Professor and Lyme expert ‌Thomas Hart is quoted.

June 3, 2025
Goodnet

MMI Postdoctoral Fellow Diego Giraldo is quoted.

June 2, 2025
2News Nevada 

MMI Assistant Professor Thomas Hart, PhD, is talks about the symptoms of tickborne diseases. 

The Economist: Babbage podcast*

Jane Carlton is a guest.

May 30, 2025 
WBAL TV (Baltimore) 

Nicole Baumgarth is interviewed. 

May 29, 2025
BBC: The Inquiry podcast

Fungi expert, Bloomberg Distinguished Professor and MMI dept chair Arturo Casadevall is interviewed by BBC's Tanya Buckett. 

May 28, 2025 
NBC's Today.com  

MMI Professor, Virologist and Vice-chair Andy Pekosz discusses summer travel impacts the spread of COVID-19. 

May 28, 2025 
The Economist: Babbage podcast*

Jane Carlton is a guest.

May 20, 2025
Wall Street Journal 

MMI Professor and Vice Chair Andy Pekosz is quoted.

May 16, 2025 
Scripps News 

MMI Professor, vice chair and virologist Andrew Pekosz comments on rising cases of measles as we approach peak travel season. 

May 14, 2025
The Washington Post 

MMI Associate Professor Kimberly Davis is quoted in this WP article about how much bacteria is in beards. 

May 13, 2025 
BioPharma Dive 

Sabra Klein, MMI Professor and co-director of the Johns Hopkins Center for Women's Health, Sex and Gender Research (CWHSGR) comments on the current state of women's health research funding.  

May 10, 2025 
The Baltimore Banner 

MMI Professor David Sullivan, MD, comments on increasing cases of babesia in Maryland, which is spread by blacklegged, or deer, ticks.  

May 8, 2025 
Bloomberg News

MMI Professor and virologist Andy Pekosz comments on the Bird Flu outbreak. 

May 4, 2025 
Miami Herald 

Professor and Virologist Andy Pekosz comments on the unpredictability of the H5N1 avian flu. 

April 26, 2025
Glamour

MMI Professor Andy Pekosz explains that H5N1 was detected in U.S. dairy cattle.   

April 25, 2025 
STAT 

MMI Professor and Virologist Andy Pekosz is quoted. 

April 15, 2025 
Bloomberg Law 

Arturo Casadevall comments on the importance of the CDC's tracking system as the drug-resistant fungus Candida auris spreads in hospitals in the U.S. and around the world. 

April 9, 2025 
WBAL-TV (Baltimore)

Johns Hopkins Malaria Research Institute (JHMRI) Director Jane Carlton is interviewed and comments on malaria control strategies. 

March 28, 2025 
Scripps News 

MMI Professor Andy Pekosz comments on the latest HHS budget cuts. 

March 26, 2025 
National Geographic

MMI Professor George Dimopoulos is quoted. 

March 23, 2025
The Baltimore Sun 

MMI Department Chair and Professor Arturo Casadevall co-wrote the guest commentary. 

March 21, 2025 
NBC News 

MMI Professor Douglas Norris comments on Alpha-gal syndrome, the allergy to red meat that is triggered by a bite from a tick, often the Lone Star tick. 

March 12, 2025
Yahoo News  

Professor Andy Pekosz comments on the latest bird flu updates including a recommendation to follow USDA cooking guidelines. 

March 10, 2025 
Scripps 

MMI Professor and Virologist Andy Pekosz discusses the recent measles outbreaks.  

March 7, 2025 
The New York Times 

Professor Sabra Klein comments on hantavirus. 

February 28, 2025
U.S. News & World Report

MMI Professor and Virologist Andy Pekosz comments. 

February 23, 2025 
Radio Health Journal 

MMI Department Chair & Arturo Casadevall, MD, PhD talks to Radio Health Journal about fungi, how global warming is forcing fungi to evolve, and why this is troubling. 

February 21, 2025 
BBC North America 

Andy Pekosz explains that scientists have seen warning signs recently that avian flu is adapting to infect humans.

February 11, 2025 
The Wall Street Journal

Andy Pekosz comments. 

February 5, 2025
Maryland Matters

MMI Professor and Virologist Andy Pekosz comments on the COVID-19 cases topping 1.5 million in the state of Maryland. 

February 3, 2025 
Reuters

Andy Pekosz comments on what is anticipated for COVID cases this spring and summer. 

January 28, 2025
NPR

Professor of microbiology Andy Pekosz comments on the safety record of existing bird flu vaccines. 

January 26, 2025 
The Baltimore Banner

MMI's Andy Pekosz is quoted.

January 23, 2025 
ABC Action News (Tampa Bay) 

David Sullivan is interviewed and comments on the benefits of convalescent plasma for the immunocompromised. 

January 21, 2025 
The i Paper (London) 

MMI Professor and Virologist Andy Pekosz comments on current vaccine recommendations. 

January 21, 2025 
Healthbeat Atlanta 

Andy Pekosz is quoted. 

January 18, 2025 
The Baltimore Sun 

Andy Pekosz is quoted.

January 17, 2025 
NPR 

Andy Pekosz is quoted. 

January 12, 2025 
BestLife 

Andy Pekosz comments on the JN.1 variant. 

January 11, 2025 
WBAL TV (Baltimore)
 
Virologist and Professor Andy Pekosz comments on the first case of H5N1 in Maryland since 2023. 

January 9, 2025 
Futurity 
(podcast)
Arturo Casadevall shares insight on the possibility of a fungal pandemic and talks about his recent book '?'
 

2024

December 26, 2024 
STAT 

Arturo Casadevall, together with Michael Joyner and R. Scott Wright, is a co-author of this Op/Ed that explains how and why convalescent plasma will play a role in future pandemics.   

December 24, 2025 
Los Angeles Times 

Arturo Casadevall is quoted.

December 16, 2024
USA Today 

MMI Professor and Virologist Andy Pekosz explains why viruses are more active in cold weather.

December 13, 2024
The Scientist 

The work of MMI Professor and Johns Hopkins Malaria Research Institute (JHMRI) Deputy Director Photini Sinnis is mentioned in this piece. 

December 11, 2024 
Medscape

Arturo Casadevall comments on the growing threat of Candida auris.

December 6, 2024
Newsreel

George Dimopoulos, an MMI Professor and Johns Hopkins Malaria Research Institute (JHMRI) Deputy Director, is quoted. His recent paper 'Chromobacterium biopesticide overcomes insecticide resistance in malaria vector mosquitoes' published in Science Advances December 4 is . 

December 6, 2024
NPR

Andy Pekosz shares his expert advice on the effectiveness of the COVID-19 vaccine options and their side effects.  

December 2, 2024 
CNN 

MMI Professor and Virologist Andy Pekosz comments on respiratory illnesses this holiday season. 

November 27, 2024 
The Washington Post 

Andy Pekosz comments on trends with Americans getting vaccines this holiday seasons. 

November 25, 2024 
The Washington Post

MMI Assistant Professor Jotham Suez comments on the efficacy of sugar substitutes. 

November 25, 2024 
Scripps News

Andy Pekosz comments on the risks of avian flu. 

November 16, 2024 
Discover

MMI Virologist and Professor Andy Pekosz discusses some ways we can differentiate between a common cold, COVID-19, and the flu. 

November 5, 2024
Science 

Arturo Casadevall comments on the Nature study. 

November 2, 2024
BBC 

MMI Professor and bacteriologist Kimberly Davis is quoted. 

November 2, 2024
The Travel 

MMI Professor and deputy director of the Johns Hopkins Malaria Research Institute (JHMRI) Photini Sinnis is quoted.

November 1, 2025
TIME

MMI Professor Sabra Klein comments. 
 
October 25, 2024 
The Naked Scientists podcast

The World Health Organization (WHO) has certified Egypt as malaria-free. Jane Carlton, Director of the Johns Hopkins Malaria Institute, discusses the implications. 

October 12, 2024 
Yahoo 

MMI Professor and Virologist Andy Pekosz explains. 

October 1, 2024 
NPR's ShortWave

ShortWave co-hosts Emily Kwong and Regina Barber interview Arturo Casadevall and MMI Postdoctoral Fellow Daniel Smith, and get a tour of the Casadevall Lab in this fun and informative 12-minute segment.  

September 12, 2024 
New York Times 

MMI Professor Sabra Klein explains some of the differences between the sexes when it comes to immune responses. 

September 6, 2024  
Bloomberg Businessweek

Kari Debbink discusses the Mpox outbreak. 

September 5, 2024 
Bloomberg Radio

Kari Debbink explains the Mpox  outbreak. 

September 4, 2024 
TIME Magazine 

Photini Sinnis comments on mosquito-borne infections. 

August 30, 2024 
WebMD 

David Sullivan, MD, and an infectious diseases physician, explains.  

August 30, 2024 
Healthline

David Sullivan is quoted. 

August 23, 2024 
Gizmodo 

Arturo Casadevall explains why fungal diseases are so dangerous. 

August 20, 2024 
WBAL TV (Baltimore) 

Professor George Dimopoulos discusses how Johns Hopkins Malaria Research Institute scientists are using genetics to fight malaria and Dengue. 

August 8, 2024 
NBC News

Mycologist Arturo Casadevall  comments on coccidioides fungus, the fungus that causes Valley fever. 

August 7, 2024
The Washington Post 

Andy Pekosz comments on the spread of the virus. 

July 25, 2024
People

MMI Professor and virologist Andy Pekosz is quoted, and his recent comments in the are referenced. 

July 23, 2024
Medpage Today

Andy Pekosz provides insight. 

July 22, 2024 
Cincinnati Enquirer

Andy Pekosz comments on the latest strains FLiRT and LB.1. 

July 21, 2024 
BBC

Andy Pekosz comments on COVID-19 this summer. 

July 18, 2024
The Washington Post

Andy Pekosz comments on the ongoing COVID-19 uptick. 

July 18, 2024
WJZ News (Baltimore)

Andy Pekosz comments on the spike in cases of COVID-19 this summer. 

July 17, 2024
CBS News

Andy Pekosz is interviewed.

July 15, 2024 
Reuters

Andy Pekosz comments on recent human cases of bird flu. 

July 11, 2024 
Telegraph (UK) 

Arturo Casadevall provides insight on Rhodosporidiobolus fluvialis, a fungal infection recently discovered in China.  

July 4, 2024 
Gothamist

MMI Professor and Virologist Andy Pekosz is quoted.

July 3, 2024 
KOAT TV (Albuquerque, NM)
 
MMI and JHMRI (Johns Hopkins Malaria Research Institute) assistant professor Conor McMeniman comments on why some people may be more attractive to mosquitoes. 

June 28, 2024 
MarketWatch

Andy Pekosz is quoted. 

June 27, 2024 
WebMD

Andy Pekosz is quoted. 

June 26, 2024 
USA Today

Andy Pekosz is quoted. 

June 24, 2024 
DNA (India)

Arturo Casadevall is quoted.

June 23, 2024 
LAD Bible

Arturo Casadevall is quoted.

June 15, 2024 
The Guardian

MMI Department chair, Bloomberg Distinguished Professor, immunologist and mycologist Arturo Casadevall  talks about his latest book and how climate change is contributing to emerging fungal pathogens . 

June 14, 2024 
CNN

MMI virologist Andy Pekosz talks to CNN about a rare flu variant that is showing some resistance to antivirals. 

June 10, 2024 
KPR Kansas Public Radio 

Arturo Casadevall is interviewed. 

June 10, 2024 
Biomes podcast 

MMI Assistant Professor Jotham Suez is the podcast guest. 

June 4, 2024 
National Journal 

Nicole Baumgarth, director of the Lyme and Tickborne Diseases Research and Education Institute is quoted. 

June 3, 2024
Goodnet

Postdoctoral Fellow Diego Giraldo, who works in the lab of MMI Professor Conor McMeniman, is quoted.

May 24, 2024
CNBC

Andy Pekosz is quoted. 

May 23, 2024 
Time Magazine 

MMI Professor and Virologist Andrew Pekosz comments on the risks of human-to-human transmission of bird flu.

May 17, 2024 
Today.com 

Andy Pekosz weighs in.  

May 16, 2024 
KPCW (Park City, UT)

KPCW’s Katie Mullaly, co-host of Cool Science Radio, and Lynn Ware Peek interview Arturo Casadevall in this 24-minute segment. Casadevall discusses his latest book  

May 11, 2024 
Live Science
, an Op/Ed written by Arturo Casadevall 

May 9, 2024 
CNN

Andy Pekosz explains how viruses break into cells. 

April 30, 2024 
WebMD 

Andy Pekosz comments on bird flu transmission  

April 28, 2024 
Financial Times 

Nicole Baumgarth, director of the Lyme and Tickborne Diseases Research and Education Institute, talks about the importance of both seeing a doctor soon after symptoms appear and taking the standard treatment of antibiotics.  

April 27, 2024 
World Today News

Jane Carlton comments on malaria in Africa and the impact of climate change on the disease. 

February 23, 2024
Infection Control Today

MMI Professor Prakash Srinivasan explains why malaria is so complex. 

February 16, 2024
Best Life

MMI Professor and Virologist Andy Pekosz shares insights on symptoms that can appear before testing positive for COVID-19. 

February 13, 2024
The Cool Down (a climate site) 

Doug Norris is quoted. 

February 11, 2024
NBC News 

Fungal infections pose greater risks to human health. Arturo Casadevall shares insight.   

January 31, 2024
NBC News

Professor and Immunologist Arturo Casadevall talks about Candida auris, the fungus the CDC is calling a serious global health threat. 

January 24, 2024 
NBC News 
 
The fungus Blastomyces dermatitidis causes the rare and sometimes fatal respiratory infection blastomycosis. Arturo Casadevall, MD, PhD is quoted. 

January 9, 2024 
Health 

Virologist Andy Pekosz explains. 

January 1, 2024 
Food, We Need to Talk podcast with Juna Gjata
MMI Assistant Professor and microbiome expert Jotham Suez is interviewed on the podcast Food, We Need to Talk with Juna Gjata. 
You can listen to the podcast on Spotify and on Apple . 

2023

December 26, 2023 
Baltimore's WMAR TV 

Andy Pekosz is interviewed. 

December 18, 2023 
AARP 
 
Andy Pekosz comments on what we can expect as we head into our fifth year with COVID-19.

November 27, 2023 
Politico 

Andy Pekosz is quoted. 

November 1, 2023 
The Week (current affairs news magazine) 

Cases of the mosquito-borne illness malaria have largely been concentrated in Africa-until now. MMI and JHMRI Professor Photini Sinnis, MD,  provides insight. 

October 25, 2023
The BMJ 

Arturo Casadevall, MD, PhD, clarifies the broad definition of the term "immunocompromised" and explains why this group can be at risk for long-term infection. 

October 23, 2023 
NBC5 Chicago 

MMI Professor and virologist Andy Pekosz talks vaccines and variants. 

October 16, 2023
WJZ CBS Baltimore

Andy Pekosz is featured.

October 16, 2023 
The Guardian Nigeria

MMI Professor George Dimopoulos is quoted. Senior Research Associate Shengzhang Dong is mentioned.

October 5, 2023 
U.S. News & World Report

MMI Professor and virologist Andy Pekosz is quoted.

September 30, 2023 
The Atlantic

Arturo ​​Casadevall is quoted.

September 27, 2023 
Telluride Daily Planet (Colorado)

Andy Pekosz is quoted.

September 26, 2023
Knowable

Arturo Casadevall is quoted.

September 19, 2023 
Today

Andy Pekosz is quoted.

September 7, 2023
Washington Post 

MMI associate scientist and virologist Kari Debbink comments on the risks of catching illnesses of airplanes.  

September Issue 
The New York Review 

Immunologist and fungi expert Arturo Casadevall and his "fungal infection-mammalian selection" hypothesis is mentioned. 

August 31, 2023 
Todayshow.com 

MMI's Andy Pekosz comments on what drives cold frequency.  

August 29, 2023
WJZ-TV (Baltimore) 

George Dimopoulos, of the Johns Hopkins Malaria Research Institute (JHMRI), is interviewed. 

August 29, 2023 
New York Times 

MMI's Andy Pekosz comments. 

August 28, 2023
WMAR TV (Baltimore)

Andy Pekosz is interviewed. 

August 28, 2023
WYPR Public Radio (Baltimore) 

MMI Professor and virologist Andy Pekosz talks boosters. 

August 28, 2023 
WBAL TV (Baltimore) 

Andy Pekosz is provides insights on the latest COVID-19 strains. 

August 25, 2023
Wired

Immunologist, mycologist and professor Arturo Casadevall explains what may be happening when fungal pathogens adapt to warmer temperatures. 

August 25, 2023
NPR 

Andy Pekosz discusses what the booster means to those over the age of 65 in this interesting and helpful Q&A. 

August 24, 2023 
Bloomberg Businessweek 

Andy Pekosz discusses the COVID surge this summer. 

August 23, 2023
MedPage Today 

David Sullivan, MD, explains why multiple preventions are better than fewer. 

August 22, 2023 
NBC News 

Dr. Photinni Sinnis provides a peak inside the Johns Hopkins Malaria Research Center (JHMRI) and explains to NBC's Tom Costello and viewers if climate change may play a role in recent U.S. cases. 

August 22, 2023 
NBC's Today Show online 

Andy Pekosz comments on the latest variant. 

August 11, 2023 
New York Times 

MMI virologist Andrew Pekosz comments on the new, dominant COVID variant EG.5.

August 10, 2023 
Bloomberg Businessweek Podcast 

Nicole Baumgarth, Professor and Director of the Lyme and Tickborne Diseases Research and Education Institute, discusses the increase in Lyme disease in the U.S. 

August 9, 2023
WJZ-TV Baltimore 

Andy Pekosz is interviewed and comments on the EG.5, the new COVID variant. 

August 8, 2023
NBC News 

Andy Pekosz talks about EG.5, the latest coronavirus subvariant. 

August 7, 2023 
CNN 

MMI's Marcelo Jacobs-Lorena discusses how an accidental discovery could stop the transmission of malaria from mosquitoes to humans. 

August 4, 2023 
Fast Company 

Doug Norris discusses some of the factors why mosquitoes are moving to higher elevations including climate change,  

July 27, 2023
Bloomberg Businessweek Podcast 

Conor McMeniman provides his expertise on mosquitoes' attraction to humans and protecting against malaria. 

July 27, 2023 
WYPR Public Radio (Baltimore) 

Nicole Baumgarth, Director of the Lyme and Tickborne Diseases Research and Education Institute is interviewed. 

July 26, 2023
Reuters 

Professor George Dimopoulos is quoted.

July  24, 2023 
WMAR TV (Baltimore) 

Virologist Andrew Pekosz is interviewed. 

July 20, 2023 
AP

Doug Norris is quoted.

July 19, 2023 
AFP Fact Check

MMI's Kari Debbink comments. 

July 14, 2023 
BBC

MMI Assistant Professor Jotham Suez discusses the WHO report on aspartame as a potential carcinogen. 

July 13, 2023 
NBC News

Jotham Suez is quoted. 

July 11, 2023 
Herald-Tribune

Photini Sinnis is quoted. 
 

Boston Globe
 
Prakash Srinivasan is quoted. 

July 6, 2023 
FOX4-TV (Cape Coral, FL)

Conor McMenamin is quoted. 

July 6, 2023 
Verywell Health 

MMI Assistant Professor Prakash Srinivasan comments on the recent cases of malaria detected in the U.S. 

July 5, 2023 
Wire News

Conor McMeniman is quoted. 

July 3, 2023 
Boston Globe
 
Prakash Srinivasan is quoted. Conor McMenamin is quoted. 

June 28, 2023 
NBC News 

MMI and Johns Hopkins Malaria Research Institute (JHMRI) Professor Photini Sinnis is interviewed. 

June 28, 2023 
MedPage Today

David Sullivan, MD, comments on cases of malaria in the U.S. 

June 25, 2023
New York Times 

MMI and Johns Hopkins Malaria Research Institute (JHMRI) Assistant Professor Conor McMeniman talks about his research and the sensory biology of how mosquitoes track and hunt humans. 

June 24, 2023
CNN

MMI and JHMRI Assistant Professor Conor McMeniman is quoted. 
 
June 21, 2023 
Economic Times 

MMI's Peter Agre is mentioned among other U.S. academics who India's Prime Minister Modi met with in New York City. 

June 15, 2023 
WYPR On The Record 

Lyme and Tickborne Diseases Research and Education Institute Director Nicole Baumgarth talks tickborne diseases and how you can protect yourself this spring. 

June 9, 2023
Deseret News 

MMI and Johns Hopkins Malaria Research Institute's Conor McMeniman discusses some of the findings from his recent Current Biology study that found mosquitoes are attracted to specific human scents and repelled by others. 

May 26, 2023
CBC Radio

Conor McMeniman discusses the findings from his lab's study which set out to create a setting to hone in on specific scents that night-hunting, malaria-carrying mosquitoes in Africa prefer in their sleeping blood meals. 

May 19, 2023
Washington Post 

MMI Assistant Professor Conor McMeniman built the ‘world’s largest perfumery for mosquitoes’ to test why some people get eaten alive while others do not. 

May 19, 2023
Science 

MMI Assistant Professor Conor McMeniman and MMI postdoctoral fellow Diego Giraldo discuss their recent Current Biology study and "the world’s largest multichoice smell test for mosquitoes”—a giant experiment to figure out why the deadly insects prefer some people over others. 

April 12, 2023 
Wall Street Journal 

Nicole Baumgarth, DVM, PhD, director of the Bloomberg School's Lyme and Tickborne Diseases Research and Education Institute comments. 

March 30, 2023
Baltimore Banner 

Fungal disease expert Arturo Casadevall discusses Candida auris, an emerging fungal threat that has been spreading in the United States since it was first reported in 2016. 

March 29, 2023
Healio Hemotology 

Convalescent plasma, when administered within 9 days of symptom onset in patients with COVID-19, may reduce the risk for hospitalization, according to data published in The New England Journal of Medicine.
David Sullivan is quoted. 

March 2023 issue 
Baltimore Magazine 

Bloomberg Distinguished Professor Nicole Baumgarth, Director of the Lyme and Tickborne Diseases Research and Education Institute, is featured as a GameChanger. She talks about the Institute, its mission and why research in the field is lacking.  

March 27, 2023
FOX-45 TV (Baltimore) 

Nicole Baumgarth, DVM, PhD, and Director of the Lyme and Tickborne Diseases Research and Education Institute explains babesiosis, recently declared an epidemic by the CDC, on Baltimore’s Fox 45.

March 22, 2023 
A Woman’s Health

Sabra Klein is quoted.

March 21, 2023 
Bloomberg 

Arturo Casadevall discusses why drug-resistant Candida auris emerging is “a harbinger of a scary future.”

March 21, 2023
Global News (British Columbia)

Arturo Casadevall comments on whether or not he thinks COVID-19 was zoonotic. 

March 20, 2023 
Washington Post 

Arturo Casadevall, MD, PhD, comments on how climate change and global warming can bring about diseases like Candida auris, the fungal infection the CDC recently announced is spreading at an alarming rate. 

March 20, 2023
Science News 

Arturo Casadevall comments on the rise of cases of Candida auris infections and antifungal resistance. 

March 17, 2023 
New York Times 

Immunologist Arturo Casadevall, who co-authored a recent study examining the origin of the coronavirus, comments. 

March 14, 2023 
Slate 

Microbiologist, immunologist & fungi expert Arturo Casadevall, MD, PhD, explains the science of a the plot centered around a Cordyceps fungus infection in the hit HBO show "The Last of Us." 

March 7, 2023 
Washington Post 

In this compelling article MMI's microbiome expert Jotham Suez discusses how artificial sweeteners and sugar substitutes can alter your microbiome in ways that are detrimental to your metabolic health.

March 7, 2023
Wall Street Journal 

Assistant Professor Jotham Suez, PhD, comments on erythritol, an artificial sweetener that is slightly less sweet than other artificial sweeteners so it is used in higher quantities in food products. 

March 6, 2023 
Los Angeles Times 

Diane Griffin, MD, PhD, discusses the body's response to viral infection and how the lingering coronavirus may drive chest pain, brain fog, fatigue and other long COVID symptoms. 

March 6, 2023 
Verywell Health 

Andy Pekosz, PhD, virologist and co-director of the Johns Hopkins Center of Excellence for Influenza Research and Response (JH-CEIRR), explains the benefits of the test which includes identifying which virus you have and which antiviral you need.

March 6
Futurity 

MMI's David Sullivan, MD, co-author of a new study in , explains that convalescent plasma works best when given early in the course of illness. 

March 1, 2023
Bloomberg 

Diane Griffin comments. 

February 27, 2023 
Bloomberg Radio 

Virologist and MMI Professor Andy Pekosz talks with Nathan Hager of Bloomberg Radio about the origins of the COVID-19 outbreak. 

February 21, 2023 
Science News

Arturo Casadevall discusses whether global warming has spurred fungi to mutate and become infectious.

February 9, 2023
Science

MMI Professor (and Vice President of the National Academy of Sciences) Diane Griffin comments on Japan’s vaccine research and development capabilities. 

February 8, 2023
Verywell Health

MMI Professor and practicing infectious diseases physician David Sullivan, MD,  discusses monoclonal antibodies. 

February 6, 2023 
STAT

Arturo Casadevall and co-authors Michael J. Joyner and Nigel Paneth provide commentary on why COVID convalescent plasma (CCP) is now better understood, and a more promising and highly effective therapy than monoclonal antibodies.  

February 4, 2023 
Bloomberg

Arturo Casadevall, MD, PhD, answers the question "Could a fungal disease emerge to cause a pandemic?"

February 4, 2023
CBC (Canadian Broadcasting Corp.) 

Arturo Casadevall discusses fungal threats. 

January 27, 2023 
Nature

Arturo Casadevall provides insight on guidelines regulating research involving dangerous pathogens. Bloomberg School immunologist Gigi Gronvall, PhD, is also quoted.  

January 27, 2023 
NPR

Arturo Casadevall and Andy Pekosz signed on to the commentary referenced in the piece.

January 20, 2023
Washington Post

Arturo Casadevall is quoted. 

January 12, 2023 
CNN 

Arturo Casadevall, a co-author in the JAMA study mentioned in the CNN article, discusses the benefits of convalescent plasma for the immunocompromised. 

January 12, 2023
Wired

Andy Pekosz is quoted.

January 11, 2023
Health News

Andy Pekosz is mentioned.

January 6, 2023 
Today.com 

Andy Pekosz is quoted.

January 1, 2023 
POLITICO

Arturo Casadevall weighs in. 

2022

December 31, 2022
CNN

Andy Pekosz is quoted.

December 31, 2022
Eat This Not That

Andy Pekosz is quoted.

December 23, 2022 
Reuters

MMI Professor Andy Pekosz is quoted.

December 12, 2022 
Medscape

Arturo Casadevall, MD, PhD, talks convalescent plasma, the only antibody-based therapy that is reliably available. 

December 10, 2022 
The Hill

MMI Professor and Virologist Andy Pekosz discusses antivirals available for both the flu and COVID. 

December 9, 2022 
U.S. News & World Report

Andy Pekosz provides insights on vaccines and circulating COVID strains.  

December 8, 2022 
WBAL TV 11 (Baltimore, Maryland)

Andy Pekosz is interviewed by WBAL-TV. (Check out his background that RoomRaters gave a 10/10!)  

December 8, 2022 
New York Amsterdam News

Andy Pekosz highlights why it is so important to pay attention to early symptoms, especially during the holidays. 

December 5, 2022 
The Hill 

Andy Pekosz why he believes the U.S. is still in the “early stages” of a surge in influenza cases

December 5, 2022 
The Baltimore Banner

Andy Pekosz comments on an early flu season and why children are being hit particularly hard. 

December 2, 2022
The Hill

Andy Pekosz discusses what the "tripledemic" of viruses means 

November 17, 2022
NBC News

Sabra Klein, MMI Professor and co-Director of the Johns Hopkins Center for Women’s Health, Sex and Gender Research, provides insights.  

November 14, 2022
USA Today

Andy Pekosz is quoted and helps explain what we need to know. 

November 13, 2022
Verywell Health  

Andy Pekosz explains that since XBB is a combination of the BA.2.10.1 and BA.2.75 sublineages, it means the subvariant has parts of two different viruses that infected the same host and exchanged some of their genes in the process

November 7, 2022
Deseret News

MMI Professor Andy Pekosz comments on the omicron subvariant BQ.1.1.  

October 31, 2022 
Fortune

Andy Pekosz weighs in. 

October 24, 2022 
Science News
 Scientists with the RECOVER Initiative say they’re working as quickly as they can to find answers.
MMI's Diane Griffin is quoted.

October 20, 2022 
Medical News Today

Preliminary studies show that cordyceps mushrooms may benefit health via anti-inflammatory, antibacterial, and antifatigue activity. Mycologist, immunologist and MMI dept. chair Arturo Casadevall is quoted.

October 18, 2022 
USA Today

Andy Pekosz is quoted.

October 1`7, 2022 
Deseret News

Andy Pekosz is quoted.

October 13, 2022 
Medical News Today

Understanding more about how MNV triggers paneth cell death—a key marker of Crohn’s disease—could lead to new treatment strategies for the condition. MMI Associate Professor Jay Bream is quoted. 

October 8, 2022 
Deseret

The omicron variant of COVID-19 is still evolving, and new omicron subvariants have a better ability to evade coronavirus drugs or immunity acquired through past infection or vaccination. Andy Pekosz is quoted.

October 5, 2022 
Global News

Andy Pekosz is quoted.

September 26, 2022 
Huffington Post

People who just had COVID-19 should follow a different timeline for the bivalent vaccine, according to MMI's Andy Pekosz and other experts. 

September 25, 2022
The Hill 

Both Moderna and Pfizer have a new FDA-authorized COVID-19 vaccine, specially formulated to ward off the omicron variant of the virus. Both vaccines are bivalent, meaning they contain parts of the original COVID-19 strain and the omicron strain that’s grown dominant in 2022. Here’s what you need to know if you’re trying to choose between the two. MMMI's Andy Pekosz provides insight. 

September 22, 2022 
Bloomberg Businessweek 
 [Podcast]
Andy Pekosz discusses the roll out of the COVID bivalent booster. 

September 20, 2022
Verywell Health 

Andy Pekosz explains. 

September 19, 2022 
Today.com

Andy Pekosz explains. 

September 17, 2022 
The Hill

Andy Pekosz is quoted.

September 3, 2022
C-SPAN
 [Video] 
Andy Pekosz discussed the latest on the new round of COVID-19 booster shots authorized by the Food and Drug Administration earlier that week and the fall COVID-19 outlook.

August 19, 2022 
ABC Australia

A new study has found some healthy adults had less control over their blood sugar levels after two weeks of consuming sugar substitutes in amounts below the recommended daily allowance. MMI's Jotham Suez, who led the study when he was at the Weizmann Institute of Science in Rehovot, Israel, is quoted. 

August 6, 2022
Fortune 

While the U.S. Centers for Disease Control and Prevention says that COVID rebounds are rare, they could be more common than we know, as most individuals with COVID stop testing after they receive a negative result.
Andy Pekosz is quoted. 

August 4, 2022
Vox

Some experts think it might be worth getting a second booster now if you face a high risk of COVID-19 exposure or if your previous dose was ages ago. The rise of BA.5 has spooked many of them, despite evidence the virus causes less severe disease now than at any other point during the pandemic.
Andy Pekosz is quoted. 

August 3, 2022
WBAL-TV 
  [Video]
Baltimore City is getting a limited number of additional monkeypox vaccines as cases in the state continue to rise. While it doesn't present the same threat as COVID-19, researchers said everyone needs to do their part to keep the virus from spreading.
Andy Pekosz is featured.

August 2, 2022 
WBAL
 [Video]
The new booster shot could be a game changer in the fight against COVID-19. The booster, designed to target the omicron variants, is expected to be approved as soon as September.
Andy Pekosz is featured. 

May 24, 2022 
The Washington Post

Monkeypox isn’t the next coronavirus.The spread of another viral infection across roughly a dozen countries may sound worrying after over two years of the coronavirus pandemic. Even President Biden raised alarms Sunday when he said monkeypox is “something that everybody should be concerned about.”
Andy Pekosz is quoted. 

May 23
The Hill

As the COVID-19 calamity has droned on, we have become accustomed to criticisms in our nation’s response. However, some things were done right.
Arturo Casadevall wrote the piece.

May 20, 2022
Verywell Health

If you’re not experiencing COVID-19 symptoms, get tested five days after having close contact with someone who has COVID-19.
Andy Pekosz provides guidance. 

May 19, 2022 
 [Radio] 
Andy Pekosz discusses the recent surge of COVID cases across the country. 

May 3, 2022 
The New York Times

Researchers don’t fully understand the menstrual cycle’s effects on the immune system, but experts say there are reasons some may feel sick at certain points.
Sabra Klein is quoted. 

April 30, 2022
Fortune

Two new Omicron variants sweeping South Africa—likely able to evade vaccines and natural immunity from previous infections—have been identified in the U.S., multiple COVID-19 researchers told Fortune.
Andy Pekosz is quoted. 

April 22, 2022
Bloomberg
 [Radio]
Andy Pekosz discusses the latest on shifting mask mandates and guidance, as well as the BA.2 subvariant

April 18, 2022 
STAT

While debilitating side effects from vaccines are rare, vaccine trials and dose recommendations tend to overlook the growing evidence that immune responses differ widely in men and women, both in response to viral infections and following vaccination.
Sabra Klein is quoted. 

April 19, 2022 
CNN.com

Arguably the most successful version of the Omicron coronavirus variant to date has been BA.2 -- but it hasn't been resting on its laurels. BA.2 has been picking up mutations, sometimes shifting into sleeker and, incredibly, even faster versions of itself.
Andy Pekosz is quoted. 

April 15, 2022 
The Washington Post

New York state officials this week announced that two new omicron subvariants, dubbed BA.2.12 and BA.2.12.1, have become the dominant forms of the coronavirus in the central part of the state. For weeks, infection rates in central New York have been at least twice the state average, according to data from the state health department. Andy Pekosz is quoted. 

April 11, 2022 
Verywell Health

The Omicron variant is now the dominant COVID-19 strain in the United States, with the subvariant BA.2 accounting for the majority of current cases. Andy Pekosz is quoted. 

April 7, 2022 
CNN

Andy Pekosz explains what he thinks the new wave of the Omicron sub-variant BA.2 cases in Europe can be attributed to.  

March 31, 2022
CNN.com

Andy Pekosz discusses why public health is very much a local thing, and why the Omicron variant is reaching around the world but different places are seeing significantly different effects.  

March 30, 2022
Bloomberg News 

Experts say studying those who have not yet caught COVID has become just as critical as studying those who have. Andy Pekosz is quoted. 

March 29, 2022
Reuters

A sub-variant of the highly transmissible Omicron version of coronavirus known as BA.2 is now dominant worldwide, prompting surges in many countries in Europe and Asia and raising concern over the potential for a new wave in the United States. Andy Pekosz is quoted. 

March 21, 2002 
WTOP
 [Radio]
It remains unclear if BA.2 will cause a spike in COVID case in the U.S., but experts believe cases will go up. Andy Pekosz is interviewed. 

March 21, 2022
WBAL-TV 
 [Video]
Andy Pekosz talks about the new omicron sub-variant, BA.2

March 17, 2022 
Bloomberg News 

Covid cases are dropping in the U.S. and mask mandates are being repealed all over. Yet over a third of the wastewater sample sites across the U.S. showed rising Covid-19 levels in the first 10 days of March. So is Covid going away or not?
Andy Pekosz is quoted.

March 14, 2022
Australian Broadcasting Corporation
  [Radio]
Health authorities around the world are keeping a close eye on the Omicron BA.2 variant, as infections continue to spread. Several countries have experienced a surge in cases. Andy Pekosz is interviewed. 

March 10, 2022
Everyday Health

Also known as hybrid immunity, super immunity describes the high levels of antibodies in vaccinated people who get breakthrough COVID-19. Andy Pekosz is quoted. 

March 9, 2022
WBAL-TV 
 [Video]
A new tool for protection against COVID-19 is now available for those most vulnerable for hospitalization and death. It is a different type of shot designed for patients who are immunocompromised and not able to build up good immunity with a vaccine alone. Andy Pekosz is featured.

March 3, 2022 
Bloomberg News 
 [Radio]
Andy Pekosz discusses the current state of Covid and how cases are starting to wane.

February 22, 2022
Advisory Board

More than 70% of Americans now have immunity against the omicron variant, according to a new model by the Institute for Health Metrics and Evaluation—a level of protection several health experts say will likely help relieve overwhelmed hospitals and blunt the impact of future surges. Andy Pekosz provides insight. 

February 21, 2022
WTOP

As omicron cases continue to decline across the region, health departments in the greater DC area have reported new cases of a subvariant strain of the illness, but this may not mean the newest version of COVID-19 will lead to another spike in cases.
Andy Pekosz explains. 

February 16, 2022
CNN.com

Lagging uptake in the US of the third vaccine is concerning public health experts. Andy Pekosz is quoted. 

February 11, 2022 
Bloomberg News 
 [Video]
Andy Pekosz discusses the path of Covid-19 infections and the emergence of new variants of the virus on "Bloomberg Surveillance."

February 9, 2022 
Medical News Today

Arturo Casadevall provides insight. 

February 7, 2022 
USA Today
 
The new 'stealth' subvariant of omicron is surging worldwide but it still makes up only a tiny portion of U.S. cases. Scientists want to know why. MMI's Andy Pekosz is quoted. 

February 1, 2022
Verywell Health 

While biology plays a role, sex-related biological differences alone are not responsible for the observed sex disparities in COVID outcomes. Sabra Klein is quoted. 

January 28, 2022 
Bloomberg TV
 
Andy Pekosz discusses the discovery of an evolution of the omicron variant and looking forward to a time where masks will not need to be worn in public.

January 21, 2022
WTOP

The D.C. area is mirroring the omicron surge and decline that has been seen in other parts of the world. COVID cases are down dramatically in much of the region, but hospitalizations are still peaking to an all time pandemic high. Andy Pekosz is quoted. 

January 20, 2022 
New York Times 

Sabra Klein shares insights. 

January 12, 2022 
Business Insider 

Andy Pekosz explains. 

January 10, 2022 
Advisory Board 

Andy Pekosz is quoted. 

January 3, 2022 
New York Times 

Andy Pekosz explains. 

2021

November 27, 2021
The New York Times

As more countries placed travel bans on southern Africa early Saturday for fear of a new and possibly more dangerous variant of the coronavirus, the passengers on two flights from South Africa found themselves caught in a pandemic nightmare.
Andy Pekosz is quoted. 

November 23, 2021
Wired

Humans have long been protected from fungal infections, thanks to our nice, warm blood. Climate change could ruin that.
Arturo Casadevall is quoted.

November 18, 2021
CNBC

Fewer Americans this year plan on taking precautions against Covid-19 when hosting or attending holiday gatherings compared with last year, signaling some return to normalcy now that 59% of the country is vaccinated against the virus.
Arturo Casadevall is quoted. 

November 16, 2021
WBAL-TV (Baltimore, MD) 
 [Video]
Cases of the flu are starting to pick up across the country. Experts expect influenza to make a comeback after it was virtually extinct last year. But COVID-19 could muddy the waters as far as the accurate reporting of those cases.
Andy Pekosz is featured.

November 11, 2021 
Bloomberg News 

Andy Pekosz discusses U.S. vaccination levels and looking towards long-term prevention of Covid-19 via booster shots.

November 2, 2021
Advisory Board

Rates of new Covid-19 cases in the United States are steadily dropping, suggesting the surge driven by the delta variant may have hit its peak—but some areas of the country are still struggling with high case rates, and the looming winter could lead to another surge in cases in some areas, experts say.
Arturo Casadevall is quoted.

November 2, 2021 
Verywell Health 

A new study looking at pregnant people with COVID-19 found that proteins and genes associated with immune responses were higher in male fetuses than female fetuses.
Sabra Klein is quoted. 

October 30, 2021
CNBC

U.S. Covid cases have fallen to less than half of the pandemic’s most recent peak, a sign that the country may be moving past the punishing wave brought on by the delta variant this summer.
Arturo Casadevall is quoted. 

October 24, 2021 
Bloomberg
 [Video]
Andy Pekosz discusses global vaccine distribution issues and the need for a broader availability of booster shots.

October 22, 2021
Bloomberg

Andy Pekosz talks about booster shots with Bloomberg's Nathan Hager.

October 18, 2021 
The Wall Street Journal

It is OK to get a flu shot and a Covid-19 vaccine on the same day, the Centers for Disease Control and Prevention says. Officials suggest getting them in different arms, or at least an inch apart if in the same arm.
Andy Pekosz is quoted. 

October 15, 2021
WIRED

When Patrick Duffy started his career at the Walter Reed Army Institute of Research in 1991, scientists were already a few years into testing a first-of-its-kind vaccine that would protect against malaria. Thirty years later, the World Health Organization has finally recommended the product of that research as a malaria intervention for children under age 5 in Africa
Prakash Srinivasan is quoted. 

October 6, 2021
WMAR
  [Video]
After a very mild flu season, doctors say we have already seen more cases than this time last year. But there’s one strain that hasn’t appeared since the pandemic hit.
Sabra Klein is featured. 

July 16, 2021
The Baltimore Sun

Whether students will be wearing masks on the first day back to school in the fall is more likely to be determined by the preferences of their parents and the district where their school is located than on current public health guidance.
Andy Pekosz and Jennifer Nuzzo are quoted.

July 16, 2021
Bloomberg 
 [Video]
Andy Pekosz discusses the county of Los Angeles, California going back to requiring the wearing of masks indoors due to the spread of the delta variant.

July 16, 2021
Politico 

Will I need a booster shot? When? Covid cases are rising in almost every state as the Delta variant attacks unvaccinated populations across the U.S. This discouraging trend, combined with Pfizer’s announcement last week that the company planned to seek approval for a Covid booster shot, has unleashed third-dose panic among the vaccinated. Bill Moss is quoted. 

July 16, 2021
Bloomberg 
 [Radio]
Andy Pekosz, professor of molecular microbiology and immunology at Johns ��ѻ��ý, talks the latest on the virus with Bloomberg's Nathan Hager.

July 15, 2021
Bloomberg 

This year, Moderna could deliver 1 billion doses of its Covid shot and bring in $19 billion in revenue. It’s become the rare biotech to hit the big time without being gobbled up by, or splitting profits with, a larger, more established company. Andy Pekosz is quoted. 

July 12, 2021
Buzzfeed News

Facing the threat of a more infectious Delta variant, vaccine-makers Pfizer and BioNTech released a statement Thursday saying it “may be beneficial” for people to get a third dose of their COVID-19 vaccine within six months to a year. But US health officials and other scientists have vehemently disagreed, saying our current vaccines are holding up really well — at least so far. Andy Pekosz is quoted. 

July 12, 2021
Sinclair Broadcast Group [via WBFF]
 [Video]
Pfizer BioNTech kicked off the debate over booster shots with a Thursday announcement that they planned to seek U.S. authorization for a third COVID-19 shot in the coming weeks. But U.S. health agencies and immunologists are pushing back, saying the evidence does not support the need for booster shots at this time. Bill Moss is quoted. 

July 12, 2021
The Baltimore Sun

Cases of COVID-19 in Maryland and around the country are way down from their winter peak, as are hospitalizations and deaths. That’s all thanks to the vaccines, which have proved highly effective in preventing severe disease, public health officials say. But the pandemic isn’t over, and the level of threat depends on where you live, your vaccination status, and now, a much more transmissible version known as the delta variant. Andy Pekosz is quoted.

July 12, 2021
Bloomberg 

Andy Pekosz discusses the severity of the delta variant and the prospect of a Covid vaccine booster.

July 9, 2021
CBS News Radio - Los Angeles 
 [Radio]
Just when you get to know a virus, it goes and changes on you. That appears to be the case with COVID, where we may not be looking at the "usual" symptoms anymore. So we will go In Depth. And as we learn more about changing symptoms .... the Delta variant has cases on the rise again.
Andy Pekosz is featured at the 17:45 mark.

July 9, 2021
The Washington Post 

The highly transmissible coronavirus variant called delta is present in all 50 states and is already dominant in many parts of the United States. Bill Moss is quoted. 

July 8, 2021
Fox News

All COVID-19-related deaths that occurred in Maryland last month involved unvaccinated people, Gov. Larry Hogan’s communication’s director tweeted Tuesday. The state saw 92 deaths last month, according to local reports. Bill Moss is quoted. 

July 7, 2021 
The Baltimore Sun

As a new, more transmissible strain of COVID-19 sweeps the country, Maryland may have positioned itself to fend off the worst of it. The Delta variant now accounts for about 25% of cases nationally and has been found in the state.
Bill Moss and Rupali Limaye are quoted.

July 7, 2021
Bloomberg
 [Video]
Bill Moss talks about the effectiveness of Covid vaccines against variants.

July 7, 2021
The Washington Post

Unvaccinated people made up all of Maryland’s reported coronavirus deaths last month, as well as the vast majority of new cases and hospitalizations, the state reported Tuesday — data that public health officials say demonstrates the effectiveness of vaccines. Bill Moss is quoted. 

July 6, 2021
CNN.com

Unvaccinated people do more than merely risk their own health. They're also a risk to everyone if they become infected with coronavirus, infectious disease specialists say. Andy Pekosz is quoted.

July 2, 2021
Washington City Paper

Experts say more information about J&J’s effectiveness against the Delta variant and the possible side effects of Pfizer or Moderna boosters is needed.
Bill Moss is quoted. 

July 2, 2021
Bloomberg
 [Video]
Andy Pekosz comments on the concerns surrounding the spread of the Covid-19 delta variant.

June 29, 2021
Verywell Health 

Research shows that a third COVID-19 vaccine dose may increase antibody levels in solid organ transplant recipients.
Bill Moss is quoted. 

June 25, 2021
Bloomberg
 [Video]
Andy Pekosz says the Covid-19 delta variant "seems to be spreading much faster than even the alpha variant," raising concerns over the return of indoor public gatherings.

June 24, 2021
Verywell Health

FDA approved the shelf life extension of the Johnson & Johnson COVID-19 vaccine from three months to four and a half months. Vaccine doses are still safe and effective, and extending the shelf life reduces further vaccine wastage. Bill Moss is quoted.

June 24, 2021
CNN.com

Vaccine makers are preparing for a next possible phase of the Covid-19 vaccine rollout: booster doses. While boosters are not necessary now, more information is needed to decide on whether people might eventually need booster doses of Covid-19 vaccines. Bill Moss is quoted. 

June 22, 2021
Advisory Board

Health experts warn that the particularly contagious delta variant may soon become the dominant strain of the coronavirus in the United States and could create "two Americas"—comparatively safe areas with high vaccination rates, and other areas with low vaccination rates and the potential for Covid-19 surges. Andy Pekosz is quoted. 

June 21, 2021
Verywell Health

The United States government will purchase 500 million doses of the Pfizer-BioNTech vaccine and donate them to low- and lower-middle-income countries. This donation won't affect vaccine availability in the U.S., experts say. Bill Moss is quoted.

June 21, 2021
The Indian Express

Trials in the UK have found a monoclonal antibody cocktail effective in some patients with severe Covid-19. What is this treatment, how does it compare with plasma therapy, and how much promise does it hold? Arturo Casadevall is quoted. 

June 21, 2021
The Boston Globe

Governor Baker said last week that not a single dollar out of $2.8 billion in federal pandemic relief funding that he plans to allocate would go toward public health programs. Emily Gurley is quoted.

June 21, 2021
McClatchy (DC Bureau)

Research shows both coronavirus infection and vaccination offers immunity that can protect people from getting sick again. But by how much and for how long remains unclear — a scientific gap that only time could fill. Sabra Klein is quoted. 

June 21, 2021
Bloomberg
 [Video]
Andy Pekosz says the U.S. is in a good place when it comes to controlling Covid-19 infections.

June 21, 2021
Axios

Public health officials are renewing calls for COVID-19 vaccinations, as a more infectious variant that can be thwarted with available vaccines is spreading rapidly in the United States. Andy Pekosz is quoted. 

June 16, 2021
WUSA9
 [Video]
Biotechnology company Novavax says it plans to submit their COVID-19 vaccine for emergency authorization. Here's everything you need to know about it. Bill Moss is featured.

June 14, 2021
The Baltimore Sun

Federal regulators at the U.S. Food and Drug Administration will authorize the use of millions of doses of Johnson & Johnson’s COVID-19 vaccine manufactured at the troubled Baltimore facility temporarily shut down earlier this year due to critical production errors.
Bill Moss is quoted.

June 14, 2021
The Hill

The Delta variant’s quick dominance over other COVID-19 strains in the United Kingdom (U.K.) is sparking concerns that the U.S. could be hit with a similar wave of new cases in the coming months. Andy Pekosz is quoted. 

June 14, 2021
NPR

The largest U.S. database for detecting events that might be vaccine side-effects is being used by activists to spread disinformation about COVID-19 vaccines. Bill Moss is quoted. 

June 11, 2021
The Miami Herald

Experts interviewed by the Miami Herald are looking to the future. Here’s what they are saying about life in 2022. William Moss is quoted.

June 10, 2021
Montana Public Radio

As health officials continue to roll out COVID-19 vaccines, making sure those vaccines remain effective against new variants of the virus is an important part of controlling the pandemic. Montana’s state health department and universities are working to stay on top of the virus evolution. Andy Pekosz is quoted.

June 10, 2021
Quillette 

The world’s attention is presently focused on the mRNA vaccines, which may turn out to be the most revolutionary vaccines ever produced. However, very few doctors, and certainly not the public, have any awareness at all of the nonspecific effects of vaccines (NSEs). Sabra Klein is quoted.

June 10, 2021
WJZ

The Johns ��ѻ��ý has new research that shows thousands of COVID-19 deaths may be linked to a drop in the use of convalescent plasma as a therapy treatment. Arturo Casadevall, study-lead, is featured.

June 9, 2021
Miami Herald

It’s 2022. And people have learned to live surrounded by COVID-19 and its many variants moving across the world.
Bill Moss is quoted.

June 8, 2021
Yahoo

The vaccination process in the U.S. has had its fair share of bumps along the road, but now there's not much standing in the way of people across the country getting the COVID shot. Bill Moss is quoted. 

June 7, 2021
Axios

Influenza cases and other common viruses have been at historically low numbers for the past year due to the safety precautions taken by the public to stifle the spread of COVID-19. But that could change soon. Andrew Pekosz is quoted.

June 7, 2021
The New York Times

Can it affect mammograms or the timing of fertility treatments? What side effects should you look out for? Experts weigh in. Sabra Klein is quoted.

June 7, 2021
ABC

Two vaccine makers have now started the process for full FDA approval. William Moss is quoted.

May 28, 2021
WUSA9
 [Video]
A Verify viewer wanted to know if getting another vaccine would affect their COVID-19 immunity. We asked the experts. Bill Moss is featured.

May 28, 2021
Bloomberg
 [Video]
Andy Pekosz says it is critically important to find the origin of the Covid-19 virus.

May 28, 2021
Scientific American

Standard treatments such as steroids, as well as illnesses such as diabetes, make the fungal infection worse.
Arturo Casadevall is quoted.

May 26, 2021
CGTN
 [Video]
Bill Moss discusses COVID-19 vaccines and the global campaign to vaccinate against the disease.

May 26, 2021
VeryWell Health

The U.S. government has shown its support in waiving intellectual property rights for the COVID-19 vaccines. Waiving patents alone is unlikely to increase global vaccine production because low- and middle-income countries still lack manufacturing capacity, technology, skills, and raw materials.
Bill Moss is quoted. 

May 24, 2021
CNN.com

As the Covid-19 vaccine rollout continues in the United States, with people ages 12 and older receiving their shots, vaccine makers are now preparing for a next possible phase: booster doses. Bill Moss is quoted.

May 24, 2021
Salon

Now, new research reveals that a person who received one dose of the Pfizer and another dose of the Moderna vaccine might actually be better than fully vaccinated. Indeed, scientists are learning more about mixing vaccine shots, and what they have found so far is encouraging. Bill Moss is quoted.

May 24, 2021
WUSA9

While vaccinated people are less likely to spread COVID-19, it’s still possible. Which means you can still spread it when locking lips with an unvaccinated person.
David Sullivan is quoted. 

May 21, 2021
Bloomberg

Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns ��ѻ��ý, discusses how vaccines are impacting pregnant women.

May 19, 2021
Scientific American

These pathogens already kill 1.6 million people every year, and we have few defenses against them
Arturo Casadevall is quoted. 

May 19, 2021
CNN
 [Transcript]
Bill Moss discusses addressing vaccine hesitancy among various populations and children's COVID case numbers in the U.S. He also talks about the CDC's new mask guidance for fully vaccinated Americans. 

May 17, 2021
Verywell Health

CVS and Walgreens, two national pharmacy chains, wasted more COVID-19 vaccine doses than state and federal agencies. Many factors can cause vaccine waste, like storage errors or broken syringes. Bill Moss is quoted. 

May 17, 2021
Bloomberg

Andy Pekosz discusses the U.S. Centers for Disease Control and Prevention (CDC) lifting mask guidance for vaccinated individuals, a return to lockdown in Singapore, and the benefit of vaccinations for kids.

May 17, 2021
Associated Press 

A New York Yankees player and several team staffers tested positive for the coronavirus although they were vaccinated, the baseball club said this week, underscoring that it’s possible to get an infection even after the shots. Bill Moss is quoted.

May 14, 2021
Business Insider

Fully vaccinated Americans don't have to mask up or social distance, the CDC announced. Experts say the change is overdue but lacks nuance. Emily Gurley is quoted.

May 14, 2021
Bloomberg
 [Podcast]
Bill Moss discusses the U.S. Centers for Disease Control and Prevention announcing that vaccinated individuals don’t have to wear a mask or socially distance in most places.

May 14, 2021
Business Insider

The Yankees' relaxed restrictions, coupled with the spread of variants, may have set the stage for breakthrough infections. Emily Gurley is quoted.

May 13, 2021 
WCNC

The current count is getting close to the low and experts are hopeful the country will reach that milestone in the coming weeks. Bill Moss is quoted. 

May 13, 2021
Forbes

Fox News’ Tucker Carlson and Sen. Ron Johnson (R-Wis.) have misleadingly pointed to the database as possible evidence that Covid-19 vaccines are deadly. Bill Moss is quoted.

May 10, 2021
NBCNews.com

More than a year after the pandemic started, Covid-19 is still ravaging parts of the world, but now scientists are warning that another virus could be a serious threat in the coming months: influenza.
Andy Pekosz is quoted. 

May 10, 2021
The Baltimore Sun

An Australian company that recently began selling a rapid at-home COVID-19 test plans to open its first U.S. production plant in Maryland later this year.
Bill Moss is quoted.

May 10, 2021
Bloomberg
 [Video]
Andy Pekosz discusses expected guidance on vaccinations for children.

May 7, 2021 
PolitiFact

Tucker Carlson was citing data from the federal Vaccine Adverse Event Reporting System database, or VAERS. The VAERS system is open to anyone, and reports to it are not verified, making it a breeding ground for misinformation about vaccine safety.
Bill Moss is quoted.

May 6, 2021
WYPR 
 [Radio]
Only a small number of Marylanders who have received their first COVID-19 vaccine shot have skipped their second dose, less than 4 percent. Bill Moss discusses the factors behind vaccine drop-off.

May 3, 2021
PolitiFact

The federal government’s Vaccine Adverse Event Reporting System helps researchers collect data on vaccine after-effects and to detect patterns that may warrant a closer look. The CDC cautions that VAERS results are not enough to determine whether a vaccine causes a particular adverse event.
Bill Moss is quoted. 

May 3, 2021
WJZ
 [Video]
Maryland added 649 new COVID-19 cases on Sunday at hospitalizations and the positivity rate continues to decline, according to information released from the state health department.
Bill Moss and Jennifer Nuzzo are featured.

May 3, 2021
Bloomberg 
 [Video]
Andy Pekosz discusses guidance from the U.S. Centers for Disease Control and Prevention (CDC) for people who have had the Covid-19 vaccine.

May 3, 2021
The Washington Post 

It is rare, but not unheard of, for people getting the Pfizer or Moderna coronavirus vaccines to contract covid-19 mid-vaccination — that is, between doses.
Bill Moss is quoted.

April 30, 2021
BestLife

Side effects are common after many shots, but we've all been paying closer attention to them than ever with the COVID vaccine.
Bill Moss is quoted.

April 26, 2021
Spectrum News New York 1
 [Video]
Pharmaceutical company Moderna announced this month it's capitalizing on the experience of developing a COVID-19 vaccine to advance more than a dozen other immunizations based in messenger RNA technology.
Andy Pekosz is featured.

April 26, 2021
WJZ
 [Video]
More than four million Marylanders have received at least their first dose of the Covid-19 vaccine Sunday, as cases and hospitalizations continue to decline, state health department officials said.
Bill Moss is featured.

April 26, 2021
WTOP
 [Radio]
The efficacy of influenza vaccines year-to-year can range between 20% and about 70%. But an immunology expert notes COVID-19 vaccines approved for use in the U.S. have efficacy rates in the 90% range.
Andy Pekosz is interviewed.

April 26, 2021
Bloomberg
 [Video]
Andy Pekosz discusses shortfalls in oxygen for Covid-19 patients in India and the need for updated guidance from the Centers for Disease Control and Prevention for people who have been vaccinated.

April 26, 2021
Reuters
 [Paywall]
Use of Johnson & Johnson's COVID-19 vaccine should be resumed in the United States despite evidence that it is linked to extremely rare but potentially deadly blood clots, advisers to the U.S. Centers for Disease Control and Prevention recommended on Friday.
Bill Moss is quoted.

April 23, 2021
Everyday Health
 [Podcast]
We’re more than a full year into the pandemic and it’s clear: Women are bearing the brunt of it.
Sabra Klein is interviewed. 

April 23, 2021
Fox56
 [Video]
With more than 50 percent of adult Americans already having their first does many people may wonder why the vaccine hurts your arm and why you may feel sick after receiving it.
Bill Moss is featured.

April 23, 2021
WJZ
 [Video]
Hundreds of people, including members of the military, now need to get a third dose of the Moderna coronavirus vaccine after officials found 800 vials were stored outside the recommended temperature for two days this month.
Bill Moss is featured.

April 23, 2021
WUSA9 
 [Video]
In general, if you can’t get the second dose within the recommended 21 or 28-day timeline, should you start the process over again, meaning two more shots?
Bill Moss is featured.

April 23, 2021
The New York Times

While scant evidence shows that plasma will help curb the pandemic, a dedicated clutch of researchers at prominent medical institutions continue to focus on the narrow circumstances in which it might work.
Arturo Casadevall is quoted.

April 22, 2021
WUSA9 

Public health experts still don't know whether a booster shot is on the horizon. But the CDC and FDA would make the final call.
Bill Moss is featured.

April 22, 2021
The Baltimore Sun

Enough appointments for COVID-19 vaccinations were available Tuesday at the mass clinic in Bowie that Maryland Gov. Larry Hogan took to Twitter around 2 p.m. to urge people to go.
Bill Moss is quoted. 

April 21, 2021
Advisory Board

After seven women developed a serious type of blood clot after receiving one of the Covid-19 vaccines, many people are questioning whether the vaccines affect women differently than men—and what women should consider as they schedule their vaccinations. Sabra Klein is quoted. 

April 21, 2021
CGTN America
 [Video]
Bill Moss discusses the pause in Johnson & Johnson's vaccine distribution after six women experienced blood clots. 

April 21, 2021 
Fox5 - DC
 [Video]
Sabra Klein joins Good Day DC to discuss the rate at which women are getting the COVID-19 vaccine in America and the effects the vaccine has on women specifically. Professor Klein is featured at the :55 mark. 

April 20, 2021
The Newsworthy
 [Podcast]
Today we’re breaking down the latest information about Johnson & Johnson’s COVID-19 vaccine. Earlier this week, the U.S. put the use of this particular vaccine on hold because of new questions about a potential rare, but serious, side effect: blood clots in the brain. Bill Moss is interviewed.

April 19, 2021
Bustle

While the current crop of COVID vaccines appear to be effective for months, experts expect that they’ll eventually start to lose their potency a little. Diane Griffin is quoted. 

April 19, 2021
The Wall Street Journal 

Scientists are asking why more women than men were affected by a rare clotting disorder seen in some recipients of Johnson & Johnson and AstraZeneca vaccines. Sabra Klein is quoted. 

April 16, 2021
Verywell Health

If you’ve only had your first dose of a two-dose COVID-19 vaccine (Pfizer-BioNTech or Moderna), it’s important to remember that you aren’t as fully protected as possible against COVID-19 just yet.
Bill Moss is quoted. 

April 16, 2021
The Baltimore Sun

The Baltimore Sun sought out to answers to some of the most frequent second dose questions. Read on to see what they found.
Bill Moss is quoted. 

April 16, 2021
Bloomberg
 [Video]
Andy Pekosz discusses what is being learned about the vaccines in use, the importance of information on vaccine-related blood clots, and steps to overcoming vaccine hesitancy.

April 15, 2021
AARP

If you're one of the 7 million Americans who received the Johnson & Johnson (J&J) COVID-19 vaccine, you may be wondering how the government's new recommendation to pause its use impacts you. Here are five things you should know.
Bill Moss is quoted. 

April 15, 2021
The Baltimore Sun

Vaccination sites in Maryland will pause the use of the Johnson & Johnson COVID-19 vaccine as federal government officials review six reported cases of an extremely rare and severe type of blood clot found in recipients of the immunization.
Andy Pekosz and Jeffrey Kahn are quoted. 

April 15, 2021
Forbes

Richer countries have the luxury of picking and choosing between vaccine options, but their regulatory decisions may make it harder for poorer countries to fight the pandemic.
Rupali Limaye and Bill Moss are quoted. 

April 15. 2021
Rolling Stone

It’s not just these severe and incredibly rare side effects — in the case of Johnson and Johnson, just six people out of more than 6.8 million vaccinated, or 0.00000088% — that are borne disproportionately by women, but a majority of mild and moderate side effects reported from the vaccine as well.
Sabra Klein is quoted. 

April 15, 2021
CBS Evening News
 [Video]
Federal health officials have asked states to pause administering the Johnson & Johnson vaccine in the U.S. after six women developed a rare blood clot.
Sabra Klein is featured at the 2:40 mark. 

April 15, 2021
The New York Times

Can it affect mammograms or the timing of fertility treatments? What side effects should you look out for? Experts weigh in.
Sabra Klein is quoted.

April 14, 2021
GBH News

The pause is also intended to give better guidance to health providers on potential symptoms to watch out for in those already given the vaccine.
Bill Moss is quoted.

April 14, 2021
WUSA9
 [Video]
Officials have recommended a pause on Johnson & Johnson vaccines after finding six notable cases of blood clotting. It doesn't compare to the risks of getting COVID.
Bill Moss is featured.

April 14, 2021
Shape Magazine

Women have an immunity advantage over men, and the latest science says that estrogen levels are partly to thank. 
Sabra Klein is quoted. 

April 14, 2021
Forbes

On Tuesday, the CDC and FDA announced they were recommending that administration of Johnson & Johnson’s Covid-19 vaccine should be paused as a possible connection to rare blood clots is investigated. Multiple states have already announced they’re suspending Johnson & Johnson shots.
Bill Moss is quoted. 

April 13,2021
WUSA9
 [Video]
Starting in March, the District modified some of its COVID-restrictions, including the provision leftover from last year that strongly encouraged nonessential employees to work from home. Residents on social media questioned how safe it really is to head back into the office.
Andy Pekosz is featured.

April 12, 2021
Healio

Researchers isolated Candida auris from a salt marsh and sandy beach in the Andaman Islands, suggesting that before its recognition as a human pathogen, it existed as an environmental fungus, they said.
Arturo Casadevall is quoted. 

April 12, 2021
Health

Experts say side effects are actually a good thing after the vaccine, so what if you feel fine?
Amesh Adalja and Bill Moss are quoted.

April 12, 2021
Bustle

Once everybody has their COVID shot this year, though, some experts are looking to the future, when you’ll need a new COVID vaccine dose, known as a booster, to deal with potential new strains of COVID and keep your immunity going strong.
Diane Griffin is quoted. 

April 12, 2021
The Washington Post

The technology used in two of the coronavirus vaccines authorized by the Food and Drug Administration may enable scientists to develop flu shots in record time, but also make inoculations that could be more effective and protect against numerous flu strains for years at a time.
Andy Pekosz is quoted.

April 9, 2021
Bloomberg
 [Video]
Andy Pekosz discusses the correlation between Covid-19 cases and deaths and the need to keep public health interventions in place as vaccinations continue.

April 7, 2021
National Geographic

Scientists say it’s only a matter of time before another deadly virus jumps from animal to human and goes viral. A new global database attempts to rank the risk from wildlife. Emily Gurley is quoted.

April 2, 2021
Miami Herald

When Miami researchers began examining the genetic structure of the COVID virus in local hospital patients about two months ago, they were impressed by the diversity of the strains. But over the last several weeks, researchers have homed in on one trait that has become increasingly prevalent in viral samples taken from patients at Jackson Health System, Miami-Dade County’s public hospital, and UHealth Tower, the University of Miami’s hospital: the E484K mutation.
Andy Pekosz is quoted.

April 2, 2021
DCist

Maryland Gov. Larry Hogan announced Thursday that all state residents 16 years and older can now pre-register online to get vaccinated at a mass vaccination site, moving up a previously announced eligibility date of April 27.
Andy Pekosz is quoted.

April 2, 2021
The Baltimore Sun

With cases of the coronavirus spiking in several East Coast states, Gov. Larry Hogan said Thursday that Maryland would aim to accelerate its COVID-19 vaccine prioritization schedule and authorize everyone 16 and older to preregister for appointments at mass vaccination sites.
Andy Pekosz is quoted.

April 1, 2021
The Baltimore Sun

Scores of Marylanders say they have found themselves trapped in cycles of dead ends and loose threads since Jan. 25, when more than 2 million state residents became eligible for COVID-19 vaccination appointments at once. The process of securing a time slot has been ruthless, fraught and confusing, particularly for those without computer skills or internet connection.
Bill Moss is quoted.

March 31, 2021
WBAL
 [Video]
In Maryland, health officials are talking about the spread of the U.K. variant. But how is it different than the older strains? And is it more transmissible in children?
Andy Pekosz is featured.

March 31, 2021
WUSA9 

There are three authorized COVID-19 vaccines in the U.S. All are safe for people with celiac disease.
David Sullivan is quoted. 

March 29, 2021
The Baltimore Sun

Now, with cases again ticking up here and in many other states, possibly driven by variants, Maryland officials are trying to get the treatment to those most at risk for severe illness.
Arturo Casadevall is quoted.

March 29, 2021
WUSA9

Medical experts explained to the Verify team that the vaccines are highly effective at stopping COVID-19, but they are not perfect. Some people will still get infected, even though they are vaccinated.
Diane Griffin and Bill Moss are quoted. 

March 26, 2021
Bloomberg
 [Video]
Andy Pekosz discusses states expanding vaccine eligibility and how vaccinations and therapeutics play into reopening plans.

March 24, 2021
Consumer Reports

If you have recovered from a COVID-19 infection, probably the last thing you want is to get the virus again. And until recently, you may have thought or hoped that once you had the disease, you were protected—like you can be from, say, chickenpox.
Andy Pekosz is quoted. 

March 23, 2021
Indiana Public Radio

Indiana opened registration beyond first responders and health care workers on Jan. 8, allowing Hoosiers 80 and older to schedule appointments for vaccines. On March 20, the state announced its expansion for Hoosiers 40 and older.
Bill Moss is quoted. 

March 23, 2021
WBAL
 [Video]
More Marylanders become eligible to get the coronavirus vaccine Tuesday when our state marks a milestone in the pandemic and enters phase two of its vaccine rollout.
Bill Moss is featured.

March 23, 2021
BBC

Opposition to the UK lockdown has led to street protests and campaigns on social media. Many of the grievances expressed have been fueled by false and misleading claims.
Andy Pekosz is quoted.

March 23, 2021
AARP

As the number of Americans getting a COVID-19 vaccine is rapidly escalating, a fourth one could be available in the United States if the federal government authorizes the use of a two-dose AstraZeneca product that the company says is 79 percent effective in protecting against moderate to severe coronavirus illness.
Bill Moss is quoted.

March 22, 2021
Los Angeles Times

When it comes to the one-two punch delivered by two-dose COVID-19 vaccines, it’s the second shot that really wallops.
Diane Griffin is quoted.

March 22, 2021
WJZ

The vaccination rush comes as the governor is about to open up eligibility. He promises everyone 16 and older will be able to make an appointment for a vaccine e by the end of next month.
Jennifer Nuzzo and Bill Moss are featured.

March 22, 2021
WTOP

COVID-19 case numbers in the U.S. are on the way down, vaccines are getting into arms and spring is coming, which last year meant a decline in cases. However, experts say now is not the time to take our foot off the brakes.
Jennifer Nuzzo and Bill Moss are quoted.

March 22, 2021
Voice of America

Testing is under way for modified versions of COVID-19 vaccines that aim to deal with coronavirus variants.Experts say current vaccines still seem to work against the variants and prevent the most severe forms of disease, though the evidence is limited. Making changes may not be necessary for all the vaccines.
Bill Moss is quoted.

March 22, 2021
National Geographic

Pain and rashes are normal responses to foreign substances being injected into our bodies. But how much pain you experience after a shot depends on a lot of factors.
Bill Moss is quoted.

March 18, 2021
FoxNews.com

After Europe was sent reeling following reports of blood clots in some people who received AstraZeneca’s COVID-19 shot, pausing vaccinations, several U.S. medical experts offered differing reactions.
Bill Moss is quoted.

March 17, 2021
Business Insider

The CDC still advises against large events, but there are ways to keep weddings relatively low-risk.
Emily Gurley is quoted.

March 16, 2021
Live Science

The findings mark the first time researchers have seen this multidrug-resistant organism in the "wild."
Arturo Casadevall is quoted.

March 16, 2021
Business Insider

The rise of contagious coronavirus variants has led to fears that they can both evade existing vaccines as well as authorized treatments like monoclonal antibodies. Convalescent plasma could still be a crucial coronavirus treatment, says an immunology professor.
Arturo Casadevall is quoted. 

March 15, 2021
Austin American-Statesman
 [Paywall]
Texas officials have blamed the low ranking on many factors: The amount of COVID-19 vaccine doses from the CDC, reporting delays and winter storms. 
Bill Moss is quoted. 

March 15, 2021
The Baltimore Sun

A day after President Joe Biden directed states to make all adults eligible for COVID-19 vaccinations by May 1, Maryland officials said they were ready to heed the call. But Ricci said the expansion of eligibility in Maryland also would hinge on the vaccine supply.
Bill Moss is quoted. 

March 12, 2021
The Baltimore Sun

With a one-dose immunization now a part of Maryland’s COVID-19 vaccine rollout, eligible residents have started to wonder for the first time whether they have a choice to make.
Bill Moss and Gigi Gronvall are quoted.

March 12, 2021
Bloomberg
 [Video]
Andy Pekosz discusses some of the data surrounding AstraZeneca's PIc's COVID-19 vaccine, emphasizing the importance of monitoring safety. 

March 12, 2021
New York Magazine

In the United States, we now have three vaccines — Pfizer, Moderna, and Johnson & Johnson — available to combat COVID-19. As the rollout of life-saving shots ramps up across the country, health experts say one thing is critical for people to understand before they roll up their sleeves: The vaccines may cause side effects.
Bill Moss and Sabra Klein are quoted. 

March 11, 2021
Scientific American

First, here’s where the experts agree: The levels of protection provided by all of the available vaccines in clinical trials were extraordinary when it came to preventing severe disease, hospitalization and death. While the new variants pose a threat, most of those interviewed believe that current vaccines should provide reasonable protection there, too.
Bill Moss and Kate Grabowski are quoted. 

March 10, 2021
International Business Times

Coronavirus vaccines have worse side effects in women, a recent study by the U.S. Centers for Disease Control and Prevention found.
Rosemary Morgan and Sabra Klein are quoted. 

March 9, 2021
National Geographic

As more people are fully vaccinated, certain activities will become less risky, but experts still recommend holding on to precautions for the near future.
Bill Moss is quoted. 

March 9, 2021
The New York Times

Men and women tend to respond differently to many kinds of vaccines. That’s probably because of a mix of factors, including hormones, genes and the dosing of the shots.
Sabra Klein and Rosemary Morgan are quoted.

March 8, 2021 
Business Insider

As pandemic fatigue sets in, many Americans have stopped following CDC rules as closely. Experts shared tips for how to hug, see friends, and take trips while keeping your risk of infection low.
Emily Gurley is quoted. 

March 8, 2021
WBAL
 [Video]
The pandemic changed how we lived our lives both together and apart, and from the beginning, leaders from D.C. to Maryland knew this was a war not a battle.
Emily Gurley is featured.

March 8, 2021
USA Today
 [Opinion]
Johns Hopkins is testing blood plasma transfusions that have COVID antibodies and this could be the way to prevent infection entirely.
David Sullivan wrote the piece.

March 8, 2021
TODAY.com

Trial data indicates that the Johnson & Johnson vaccine is just as good at preventing hospitalization and death as other candidates.
Bill Moss is quoted.

March 5, 2021
Bloomberg
 [Video]
Andy Pekosz discusses expanding vaccinations to younger people and public campaigns to boost vaccine acceptance.

March 5, 2021
STAT
 
During the Covid-19 pandemic, clinicians have seen many remarkable things. Among them is how a 19th-century therapy called convalescent plasma came to be used in more than 500,000 hospitalized Covid-19 patients the United States and elsewhere.
Arturo Casadevall coauthored the piece.

March 4, 2021
Detroit Free Press

The race between COVID-19 vaccines and the more contagious viral variants has intensified. As the U.S. struggles to ramp up COVID-19 vaccinations — with only a fraction of the population vaccinated — we need to explore other options to treat those who have been exposed to the virus, curb dangerous outbreaks and save lives.
David Sullivan wrote the piece.

March 4, 2021
Healthy You
 [Podcast]
People are going to great lengths to get the COVID-19 vaccine shot. But while national attention is on the COVID vaccine, the use of other vaccines is dropping in the US and around the world, posing new threats to public health
Bill Moss is interviewed.

March 4, 2021
The New York Times

It’s not clear how easily vaccinated people may spread the virus, but the answer to that question is coming soon. Until then, scientists urge caution.
Sabra Klein is quoted.

March 4, 2021
Deseret News

The Centers for Disease Control and Prevention has some tips for dealing with COVID-19 vaccine side effects
Bill Moss is quoted.

March 4, 2021
WAND17-TV

The Diocese of Springfield sided with other Catholic leaders in asking members to avoid using the Johnson and Johnson COVID-19 vaccine due to moral questions raised about the use of fetal cell lines in its production.
Amesh Adalja and Bill Moss are quoted.

March 3, 2021
The Swaddle 

A growing body of research into the immune system’s response to Covid-19 and other viral infections is shedding light on differences between male and female responses that leave men more at risk of severe illness and death.
Sabra Klein is quoted. 

March 3, 2021
The Scientist

Stronger interferon production, greater T cell activation, and increased susceptibility to autoimmunity are just some of the ways that females seem to differ from males.
Sabra Klein is quoted.

March 1, 2021
The Daily Express (UK)

The Nipah virus could be used as a weapon by bio-terrorists because of its "high fatality rate and ability to cause public fear" and has is considered a threat "that needs to be addressed", experts have claimed.
Emily Gurley is quoted.
NOTE: This story also ran in 

March 1, 2021
BestLife

However, they also found that there are some minor side effects and two of these are much more likely to occur after your second shot: fever and chills
Bill Moss is quoted.
NOTE: This story also ran in  and .

March 1, 2021
Science News

Lopsided distribution will cost lives, ding the global economy and perpetuate the pandemic
Bill Moss is quoted.

March 1, 2021
Refinery29

As of Friday, over 68 million doses of the vaccine have been administered nationwide.
Arturo Casadevall is quoted.

February 26, 2021
The Washington Post

The anticipated authorization of a third coronavirus vaccine has raised a new question for many Americans: Which shot should I get? The answer, experts say, is whichever one you can.
Bill Moss is quoted.
NOTE: This story ran elsewhere, such as  and .

February 26, 2021
VOA
[VIDEO] 
Drug company officials say they are speeding up delivery of COVID-19 vaccines in the United States. With more vaccine plants online, they say they can produce enough vaccine by the end of July to cover nearly the entire U.S. population. But low-income countries are still at the back of the line.
Bill Moss is featured.

February 26, 2021
WUSA9 (CBS Washington, D.C.)

The FDA is expected to approve Johnson & Johnson's vaccine for emergency use. Here's how it differs from the other vaccines on the market.
Bill Moss contributed.

February 26, 2021
Bloomberg
[VIDEO] 
Andrew Pekosz is featured.

February 25, 2021
Deseret News

The COVID-19 vaccine continues to roll out. But people have reported feeling symptoms of a cold — fever, fatigue and more — after getting a second shot. Experts want to calm fears over those symptoms, though.
Bill Moss is quoted.

February 25, 2021
WBAL (NBC Baltimore)

Promising news about Johnson & Johnson's COVID-19 vaccine candidate comes the day before Maryland opens its third mass vaccination site.
Bill Moss is quoted.

February 25, 2021
Newsweek

As of Tuesday, over 65 million people across the U.S. had been given a Pfizer or Moderna COVID vaccine.
Bill Moss is quoted.
NOTE: This story ran elsewhere, such as on .

February 24, 2021
The Washington Post

‘Go ahead and . . . get them ready to go,’ U.S. official urges manufacturers on updated vaccines.
Bill Moss is quoted.

February 24, 2021
TODAY

While about a third of the people who receive the vaccine have symptoms that "seem like the flu," that's an expected immune response.
Bill Moss is quoted.

February 24, 2021
AARP

Medical experts explain why there's little reason to worry about your medications
Bill Moss is quoted.

February 23, 2021
Los Angeles Times

The U.S. Food and Drug Administration issued new guidance Monday that streamlines the vetting process for COVID-19 vaccines that are modified to target new coronavirus variants.
Diane Griffin is quoted. 

February 23, 2021
Los Angeles Times

Scientists are still unsure of the exact threshold that will be necessary to reach herd immunity against the coronavirus. Some estimate it could happen when 50% of people are immune; others think the figure is closer to 90%.
Diane Griffin is quoted. 

February 22, 2021
The Washington Post 

Biden administration officials, pharmaceutical companies and scientists are racing to get ahead of a coronavirus that has become a more aggressive shape shifter than many expected. But they are still struggling to answer basic questions about where the variants are spreading, how quickly to update the vaccines and whether more problems are just over the horizon.
Bill Moss is quoted. 

February 22, 2021
Today.com

It's not a sign that the vaccines have failed. Data seems to indicate that post-vaccination coronavirus cases are mild.
Bill Moss is quoted.

February 22, 2021
Bloomberg
 [Video]
Andy Pekosz says the U.S. has to get better at distributing the Covid-19 vaccines and expects pandemic-related restrictions to be relaxed by midyear.

February 22, 2021
The Baltimore Sun

The grim milestone comes roughly one year after the first coronavirus death in the United States.
Lisa Cooper, Bill Moss and Gigi Gronvall are quoted. 

Februry 22, 2021
WJZ
 [Video]
Maryland has now administered one million COVID—19 vaccination doses, but supply issues remain. As of Friday, only 5% of people in Baltimore City and 6.8% of people in Baltimore County have been fully vaccinated.
Bill Moss is featured.

February 19, 2021
The Salt Lake Tribune
 [Opinion]
Blood plasma from recovered COVID-19 patients could be key to setting us free without having to wait for vaccines to reach everyone. This type of plasma — also called high-antibody-titer convalescent plasma — has already been used to successfully treat more than 400,000 hospitalized U.S. patients. Could it help stop the virus’ progression, if given to patients at an earlier stage of their illness?
David Sullivan wrote the piece.

February 19, 2021
New Hampshire Public Radio
 [Radio]
Mutations in viruses occur continually and though many don't result in changes in disease severity or immune response, COVID-19 has mutated in some ways that concern scientists.
Bill Moss is interviewed.

February 19, 2021
WHYY

Public health laboratories in New Jersey and Delaware are working to do more investigations of the genetic data of coronavirus samples, to identify new variants sooner and see how the virus is spreading.
Diane Griffin is quoted.

February 19, 2021
Associated Press

As states lift mask rules and ease restrictions on restaurants and other businesses because of falling case numbers, public health officials say authorities are overlooking potentially more dangerous COVID-19 variants that are quietly spreading through the U.S.
Diane Griffin and Caitlin Rivers are quoted.

February 18, 2021
NPR
 [Radio]
Scientists are evaluating domestic COVID-19 variants to see whether they pose a new threat, as public health experts warn the U.S. needs better surveillance to spot mutations and slow their spread.
Andy Pekosz is interviewed.

February 18, 2021
Today.com

Experts weigh in on the latest iteration of pods or bubbles, which aim to provide social interaction as people become fully vaccinated.
Bill Moss is quoted.

February 16, 2021
Associated Press

A decentralized vaccine campaign has resulted in a patchwork of policies that differ from state to state, and even county to county in some areas, resulting in an inconsistent rollout to low-paid essential workers who are exposed to hundreds of customers each day.
Bill Moss is quoted.

February 15, 2021
Global News - Canada

As highly-infectious variants of the novel coronavirus spread around the world, there are mounting questions on how best to keep Canadians safe. Once again, travel is in focus as attention shifts from declining cases in Canada to these new threats from abroad.
Andy Pekosz is quoted. 

February 12, 2021
Indiana Public Radio

The state extended vaccine appointments to Hoosiers 65 and older on Feb. 1. Originally, health officials had anticipated opening appointments to Hoosiers 60 and older, but decided to split that group in half in response to the federal allocation of vaccines.
Bill Moss is quoted.

February 12, 2021
Bloomberg
 [Video]
Andy Pekosz discusses expanding vaccination efforts in the U.S., lessons learned from Israel’s vaccination success, and discovery of further Covid-19 variants.

February 11, 2021
Los Angeles Times

The second shot of the COVID vaccine does not need to happen precisely 21 or 28 days after the first to be effective.
Diane Griffin is quoted. 

February 11, 2021
National Geographic

As more people are fully vaccinated, certain activities will become less risky, but experts still recommend holding on to precautions for the near future.
Bill Moss is quoted.

February 10, 2021
WFAE
 [Radio]
In many states, when you sign up for a COVID-19 vaccine, it is up to you to tell the truth about whether or not you're eligible. It's an honor system, but that system doesn't always work.
Bill Moss is interviewed.

February 10, 2021
Global News

Canada has reported a first case of a new potentially more contagious Brazilian variant of the coronavirus. The case involves a Toronto resident, who is hospitalized and had recently travelled from Brazil, city health officials confirmed on Sunday.
Andy Pekosz is quoted.

February 10, 2021
NPR

Right now in Washington state, workers in health care settings, nursing home residents and staff, first responders, people 65 or older, and people 50 or older who live in multi-generational homes are eligible for the vaccine. But, in some cases, younger people, and people who work in professions not yet eligible, have received vaccine appointments.
Bill Moss is quoted.

February 8, 2021
Los Angeles Times

The J&J vaccine didn't appear to perform as well as others in clinical trials. But scientists say it is impossible to know whether any one vaccine is better.
Arturo Casadevall is quoted.

February 8, 2021
Voice of America

On January 29, the company, a division of health care giant Johnson & Johnson, announced its shot was 66% effective against moderate to severe COVID-19. It's a lackluster result compared with the 95% that Pfizer-BioNTech reported for its vaccine, or Moderna's 94%. But those headline efficacy figures obscure an important point: Against the most serious cases, the shot was very effective.
Jennifer Nuzzo and Bill Moss are quoted.

February 8, 2021
Voice of America
 [Video]
The first vaccines against COVID-19 have gone mostly to wealthier countries. Now, several middle-income countries are getting their shots. Many come from Chinese and Russian drugmakers. But critics note that these developers have not been forthcoming with data on their vaccines' safety and efficacy.
Bill Moss is featured at the 2:25 mark.

February 5, 2021
WUSA9

Squalene is a fat molecule harvested from the oil in shark liver, and it has been used as an additive to a few COVID-19 vaccines in development.
Andy Pekosz is quoted. 

February 5, 2021
Bloomberg
 [Video]
Andy Pekosz discusses known variants of the coronavirus and modeling of global vaccination rates.

February 5, 2021
Bloomberg
 [Podcast]
Bill Moss, Executive Director of the International Vaccine Access Center at the Johns ��ѻ��ý, provides a coronavirus and vaccine update.

February 4, 2021
USA Today

More than a month since the U.S. first began administering COVID-19 vaccines, many people who were not supposed to be first in line have received vaccinations. Anecdotal reports suggest some people have deliberately leveraged widespread vulnerabilities in the distribution process to acquire vaccine. Others were just in the right place at the right time.
Bill Moss is quoted.

February 2, 2021
KUOW

Across Washington state, people ineligible for the vaccine are getting it anyway, including the archbishop of Seattle. Meanwhile, hundreds of thousands who are eligible haven’t been able to score an appointment.
Bill Moss is quoted.

February 2, 2021
Business Insider

Israel has immunized more people per capita than any other country. As of Thursday, nearly a third of Israel's population — 2.8 million out of 9 million residents — had gotten a first shot, and more than 1.6 million people had received the full two-dose regimen.
Emily Gurley is quoted.

February 2, 2021
The Baltimore Sun

State health officials have detected Maryland’s first case of the South African variant of the coronavirus in the Baltimore area, Gov. Larry Hogan announced Saturday.
Bill Moss is quoted.

February 2, 2021
Bloomberg

More Americans have received at least one dose of a Covid-19 vaccine than have tested positive for the virus, an early but hopeful milestone in the race to end the pandemic.
Bill Moss is quoted.

February 2, 2021
Bloomberg
 [Video]
Andy Pekosz discusses nationalization of vaccines and the efficacy of vaccines against variants.

February 2, 2021
The Washington Post

The new, highly transmissible coronavirus variant first identified in South Africa has emerged in Maryland, Gov. Larry Hogan announced Saturday, marking the second state to report a confirmed case of the mutated virus.
Andy Pekosz is quoted.

February 2, 2021
C-SPAN's Washington Journal
 [Video]
Andy Pekosz of Johns ��ѻ��ý talked about the latest developments on COVID-19 vaccines and emerging variants.

February 2, 2021
C-SPAN's Washington Journal
 [Video]
Andy Pekosz of Johns ��ѻ��ý talked about the latest developments on COVID-19 vaccines and emerging variants.

January 28, 2021
Los Angeles Times

One of the inescapable patterns of the pandemic has been how the virus does not touch all lives equally: Along with the elderly and those with underlying health conditions, people who are Black, Latino or poor have experienced a disproportionate number of serious illnesses and deaths.
Diane Griffin is quoted. 

January 28, 2021
FoxNews.com

The widow of a California health care worker who died after receiving the second dose of Pfizer's COVID-19 vaccine says her late husband "believed in vaccines."
Bill Moss is quoted.

January 27, 2021
Los Angeles Times

California is just clawing itself out of a devastating surge that made it the epicenter of Americans’ COVID-19 pandemic. All but four of the state’s 58 counties are in the highest-risk purple tier, where transmission of the virus is “widespread.”
Diane Griffin is quoted.

January 25, 2021
Elemental

Men have a greater risk of developing severe Covid-19 infections and ultimately dying from the disease. Not only is that a trend doctors have observed since the beginning of the pandemic, it’s also the finding of a recent study that pooled data from over 3 million people from 47 countries.
Sabra Klein is quoted.

January 25, 2021
The Baltimore Sun
 [Commentary]
The FDA approved convalescent plasma for hospital use under Emergency Use Authorization last August, when it met the regulatory criteria of probable efficacy and definite safety. Unfortunately, the rollout of that authorization was marred by errors during a presidential news conference, where efficacy was mistakenly exaggerated. This created an unnecessary controversy that colors the view of plasma to this day.
Arturo Casadevall coauthored the piece.

January 25, 2021
FoxNews.com

The serious outcomes that may arise from COVID-19 disease, like hospitalization and death, far exceed side effects from vaccines.
Bill Moss is quoted. 

January 22, 2021
Bloomberg
 [Video]
Andy Pekosz discusses ways to improve the U.S. vaccination process and the level of vaccinations needed to curb the coronavirus pandemic.

January 20, 2021
Independent

The nation’s leading experts are calling on the new president to create mass vaccination sites, improve genome sequencing and rejoin the World Health Organization.
Bill Moss is quoted. 

January 19, 2021
WBEZ - Chicago

Following these guidelines is more critical than ever in this stage of the pandemic, with surging numbers in many parts of the world along with the discovery of seemingly more contagious strains of COVID-19. Emily Gurley is quoted.

January 19, 2021
WBAL

Baltimore Mayor Brandon Scott is calling on Gov. Larry Hogan to set up mass COVID-19 vaccination sites to speed up vaccinating the city population. Bill Moss is featured.

January 19, 2021
The Baltimore Sun

The plan to implement Maryland’s new policy enabling adults 65 and older to start getting inoculated for COVID-19 lacks critical details that officials and experts say could hamper the ability to ensure all those who want the vaccine can get it anytime soon. Ruth Faden and Bill Moss are quoted.

January 19,. 2021
WBUR
 [Radio]
Governors across the country are expressing frustration with the Trump administration over a slowdown in the rate of vaccination against COVID-19. States are facing a shortfall in the number of doses promised by the federal government, as a more infectious variant of the coronavirus is spreading. Bill Moss is interviewed.

January 19, 2021
The Huffington Post

Do the COVID-19 shots prevent infection? How long does immunity last? Do they work against mutations? Here's what to know. Bill Moss is quoted.

January 15, 2021
Miami Herald

Florida health officials recently asked labs reporting COVID-19 cases to include a new data point: how long it took for the specimen used in the test to register as positive, a measure that can indicate how much virus is present.
Rachel West is quoted.

January 15, 2021
Bloomberg 

Andy Pekosz discusses the understanding of Covid-19 variants and targets for vaccine rollouts in the U.S.

January 13, 2021
McKnight's Senior Living

Experts discuss various approaches to help senior living communities navigate their approach during the pandemic. 
Bill Moss is quoted. 

January 13, 2021
Newsy

Experts say additional vaccine brands, increased manufacturing and more money for distribution needed to accomplish Biden's 100 million dose promise.
Bill Moss is featured.

January 12, 2021
AFP Fact Check

A speech by a biomedical researcher claiming that 21 percent of patients from the Moderna vaccine trial have experienced severe adverse events has been shared thousands of times on social media since December 11. This claim is false.
Bill Moss is quoted.

January 8, 2021
Miami Herald

The mutated and likely more contagious strain of the novel coronavirus detected in Martin County last week is growing in Florida, with 22 cases now in the state, according to new data from the Centers for Disease Control and Prevention.
Gigi Gronvall and Rachel West are quoted.

January 7, 2021
Fox35 - Orlando

A top health official says the U.S. should consider cutting the Moderna COVID-19 vaccine dose in half to serve more people. Others say this is premature.
Bill Moss is featured.

January 6, 2021
CGTN

With vaccine roll-outs across Europe and several other parts of the world already under way, it is common for people to want to understand what it is they're being given and what to expect from it.  Bill Moss is mentioned.

January 5, 2021
WBFF

On Monday, the Maryland Department of Health reported 5,923 people received the COVID-19 vaccine in the last 24 hours. That brings the state’s total number of vaccinations to just shy of 66,000. Three weeks since vaccinations got underway nationwide and MDH says just 1.09% of Maryland is vaccinated.
Bill Moss is featured. 

January 5, 2021
Fortune

An easier-to-spread variant of COVID-19 detected in the U.S. could intensify the virus’s surge, if it hasn’t already, boosting the urgency for a speedier, more effective vaccine push. Andy Pekosz is quoted.

January 5, 2021
Bloomberg

Bill Moss discusses issues with the rollout of Covid-19 vaccines in the United States.

January 4, 2021
CNN.com

When biotech company Moderna announced Tuesday that it planned to offer its workforce a chance to get vaccinated with its recently authorized Covid-19 vaccine, their decision raised some eyebrows.
Bill Moss is quoted.

January 4, 2021
NBCNews.com

The new variant, dubbed VUI-202012/01, is believed to be more contagious but not more lethal than other strains.
Diane Griffin is quoted.

January 4, 2021
USA Today

In attempts to push baseless and debunked claims that the coronavirus pandemic is a hoax, some social media users are sharing a lengthy statement that claims to be authored by a professor at Cornell University.
Andy Pekosz is quoted.

January 4, 2021
WBNG

With the ongoing pandemic, the Red Cross needs the help of blood and platelet donors to meet the needs of patients, but if you have received the COVID-19 vaccine it might impact the next time you donate.
Bill Moss is quoted.

January 4, 2021
Business Insider

As the US rejoiced over the results of two coronavirus vaccine trials in November, a significant drug advancement slipped by relatively unnoticed.
Arturo Casadevall is quoted.

January 4, 2021
WUSA9 - DC
 
There's new variants of the SARS-CoV-2 virus hitting South Africa and the United Kingdom. Our Verify experts says its normal for a virus to mutate over time
Bill Moss is featured.

January 4, 2021
WUSA9 - DC

Reports of new variants of the SARS-CoV-2 virus are popping up globally, will the current COVID-19 vaccines protect us against them?
Bill Moss is featured.

2020

December 23, 2020
NBC Palm Springs
 [Video]
As the vaccines slowly continue to roll out across the country, COVID continues to kill a record number of Americans, many say they will opt out when it’s their turn to get protection against COVID-19.
Bill Moss is featured.

December 23, 2020
The Boston Globe

Lags in notifications from COVID-positive patients, contacts refusing to take calls from tracers, and other issues are making it impossible to reach contacts quickly enough to control outbreaks.
Emily Gurley is quoted.

December 22, 2020
STAT

A variant of the coronavirus that emerged in the United Kingdom has forced London to shut down, led some countries to ban travel to and from the U.K., and set off a global manhunt to find out where else this version has arrived.
Diane Griffin is quoted.

December 18, 2020
Bloomberg

Andy Pekosz discusses concerns about the holidays in the U.S. and the distribution and availability of Covid-19 vaccines.

December 18, 2020
TIME

But compared to our typical seasonal flus, what makes SARS-CoV-2 dangerous is that it’s a brand new virus. When it first started spreading around the world, none of our immune systems had experience with it, and it took scientists time to develop effective tests for it, let alone treatment methods and the vaccines that have just recently begun rolling out.
Andy Pekosz is quoted.

December 18, 2020
CNN

The Moderna coronavirus vaccine was recommended for emergency authorization by an FDA panel, following the FDA approval of the Pfizer vaccine last week. CNN's Brian Todd reports on how the two vaccines are different, and why experts say that shouldn't matter.
Bill Moss is featured at the 1:51 mark.

December 17, 2020
Verywell Health

On Friday, December 11, the Food Drug and Administration (FDA) approved the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization. Many are looking toward the vaccine as a possible solution to the rising COVID-19 cases forcing institutions—like schools—across the country to close. However, despite the approval and dissemination of the Pfizer vaccine, some experts believe vaccine mandates in schools are unlikely to happen.
Bill Moss is quoted.

December 16, 2020
Scripps [via WMAR]
 [Video]
Now that Pfizer's COVID-19 vaccine has the green light, medical experts are working to debunk vaccination myths.
Bill Moss is featured.

December 15, 2020
Indiana Public Media

Indiana will begin receiving its first doses of COVID-19 vaccines this week, and anticipates receiving more at least weekly. The state’s first phase of initial doses will go to health care workers and long-term care facility residents.
Bill Moss is quoted.

December 15, 2020
Milwaukee Journal Sentinel

Wisconsin expects to receive 49,725 doses of the Pfizer vaccine this week. Soon after, the state should receive about 101,000 doses of the COVID-19 vaccine made by Moderna as long as the company receives emergency use authorization from the U.S. Food and Drug Administration. Both vaccines require that people receive two shots, separated by a few weeks.
Bill Moss is quoted.

December 14, 2020
WBAL

One day after an FDA advisory panel signed off on the Pfizer coronavirus vaccine and with emergency use authorization expected sometime in the next 24 hours, experts at the Johns ��ѻ��ý shared a virtual update on what they’ve learned so far, and what challenges we face moving forward.
Bill Moss is featured.

December 11, 2020
Verywell Health

Although immunity is offered through Pfizer and Moderna’s vaccines, building immunity against COVID-19 takes time and will still require social distancing and mask-wearing. While experts think it may last years, immunity duration is unknown. Therefore, more studies will need to be conducted.
Bill Moss is quoted.

December 11, 2020
Elemental

Clear guidance on everything you want to know about the vaccine (and then some).
Bill Moss, Rupali Limaye and Rene Najera are quoted.

December 11, 2020
Cleveland.com

Body aches, fever, chills and fatigue. The proposed COVID-19 vaccines will protect you from one bug, but make you feel as if you’ve been hit by another. Why take a vaccine that has a chance of making you feel bad? People who get immunized have a lower chance of getting the illness and taking up a bed in an already overtaxed hospital.
Rupali Limaye and Bill Moss are quoted.

December 11, 2020
Tegna [via WQAD]

Many have asked if the vaccines being considered for COVID-19 could make recipients contagious to at-risk immunocompromised people like some past vaccines.
Bill Moss is quoted.

December 11, 2020
CIDRAP

Although the country is in the midst of the darkest period of the coronavirus pandemic, with emergency authorization of a COVID-19 vaccine imminent and distribution of initial doses expected to start this month, the beginning of the end is starting to come into focus.
Bill Moss is quoted.

December 11, 2020
The Huffington Post

We are getting closer and closer to a COVID-19 vaccine becoming available. And, like most vaccines, there will probably be mild to moderate side effects. But many experts believe the benefits of getting immunized far outweigh potential issues if it means people are protected against the coronavirus.
Bill Moss is quoted.

December 11, 2020
Bloomberg

Andy Pekosz discusses guidelines on masks, medical restrictions on Covid-19 vaccines, and concerns about vaccine distribution to poorer nations.

December 11, 2020
NBCNews.com

From vaccine deserts to pricing and timing, there is a lot we know about forthcoming vaccines — and some crucial unknowns.
Bill Moss is quoted.

December 10, 2020
Tegna [via KARE11 News]

Viral posts claim one of the new coronavirus vaccines uses fetal cells, but experts say that's not true. Here are the facts.
Bill Moss is quoted.

December 10, 2020
The Quicky

When Pfizer announced that their experimental COVID-19 vaccine has an efficiency rate of over 90% it not only made the world rejoice that there may finally be some light at the end of the virus tunnel, it also sent the stock market soaring.
Bill Moss is interviewed.

December 10, 2020
AARP

The unprecedented speed of vaccine development has generated a number of misconceptions that have fueled skepticism among some Americans. Here are some prevalent coronavirus vaccine myths and the truth behind the medicines designed to combat COVID-19.
Bill Moss is quoted.

December 9, 2020
Yahoo

The COVID-19 vaccine is just days to weeks away from becoming a reality. However, while the FDA confirmed on Tuesday that the Pfizer vaccine appears to meet the standard for emergency use authorization, confirming both its safety and efficacy, there are still a lot of people who are concerned about its potential side effects.
Bill Moss is quoted.

December 9, 2020
WMAR

This week, the FDA will evaluate the first COVID-19 vaccine for Emergency Use Authorization, from Pfizer. In anticipation of its approval, state and local health officials spoke about how they are getting ready.
Bill Moss is featured.

December 9, 2020
Science News

The U.S. Food and Drug Administration is gearing up to consider emergency use authorization for Pfizer and BioNTech’s COVID-19 vaccine on December 10 and for Moderna’s on December 17. But there are still crucial questions about how these vaccines and others will work once they get injected into people around the world.
Bill Moss is quoted.

December 9, 2020
Tegna [via KGW]

In this time of pandemic, many people have avoided loved ones who are frail for fear of possibly spreading COVID-19. The people at risk include those whose immune systems have been weakened by chemotherapy or by other conditions. But when vaccines against the coronavirus get the OK, could the recently immunized possibly pass on COVID-19?
Bill Moss is quoted.

December 9, 2020
Voice of America

Vaccines against COVID-19 may begin arriving within days in the United States, as the fastest-ever vaccine development reaches a conclusion. Experts say no corners have been cut. But the U.S. Food and Drug Administration (FDA) is considering authorizing the vaccines after a shorter-than-normal safety testing period.
Bill Moss and Rupali Limaye are quoted.

December 9, 2020
NBCNews.com

Pfizer's Covid-19 vaccine candidate offers some protection after the first dose, with nearly full protection after the second dose, according to documents released Tuesday by the Food and Drug Administration.
Bill Moss is quoted. 

December 9, 2020
CNN.com

Experts are urging anyone whose already been infected with COVID-19 to get a vaccine once they're available to the public.
Bill Moss is quoted.

December 8, 2020
WebMD

Nurse researcher Kristen Choi, PhD, experienced first-hand a "worst-case scenario" of potential side effects after receiving an experimental COVID-19 vaccine in a phase III trial. She says providers should be prepared to reassure patients if reports of similar experiences spread when vaccine rollouts begin.
Bill Moss is quoted.

December 8, 2020
WBAL

The Baltimore Ravens activated quarterback Lamar Jackson, fullback Patrick Ricard, long snapper Morgan Cox and defensive tackle Justin Madubuike from the Reserve/COVID-19 list. The team is reporting that there were four different strains of the virus in their facilities and that three of the strains were stopped with only one causing the outbreak in the facility.
Andy Pekosz is featured. 

December 8, 2020
WBAL
 
As Maryland inches closer to the rollout of a COVID-19 vaccine, state and local health officials are preparing in several ways. A vaccine for COVID-19 could be rolled out in a little more than a week, and local health officials say educating people is one of their biggest challenges.
Bill Moss is featured.

December 8, 2020
The Baltimore Sun

Maryland health officials will embark soon on a multifaceted messaging campaign — possibly featuring celebrities, faith-based leaders and trusted “community messengers” — to entice state residents to get COVID-19 vaccines.
Bill Moss and Jinlene Chan are quoted.

12/04/20
United Press International

The effectiveness of new vaccines developed to prevent COVID-19 likely depends on how well they are distributed and the degree to which the public is willing to take them, public health experts said.
Bill Moss is quoted.

12/04/20
WMAR

Johns Hopkins vaccine experts say even with highly effective vaccines ready for emergency use authorization, there are still lots of hurdles to get over... from distribution to getting people to accept the vaccine.
Bill Moss and Rupali Limaye are featured.

12/04/20
WBAL

It's now estimated that Maryland will have enough doses of a coronavirus vaccine by the end of December to at least cover health care employees. During an afternoon briefing, experts from the Johns ��ѻ��ý detailed the challenges ahead.
Bill Moss is featured.

12/04/20
The Baltimore Sun

Vaccines designed to mitigate the scope and severity of the coronavirus pandemic could be distributed to millions of Americans before the end of December, health officials said this week. But much about the vaccines — such as the duration of immunity they offer, possible long-term side effects and variance across different ages, races and ethnicities — will likely take another year or so to understand.
Bill Moss and Rupali Limaye are quoted.

12/04/20
WTOP

A pair of COVID-19 vaccines could be approved for use in the U.S. within weeks, but there are still several unknowns, including duration of immunity.
Bill Moss is quoted.

12/04/20
Newsweek

The potential rare, and long-term side effects of COVID vaccines may emerge—if they do at all—after millions of people are immunized, experts have told Newsweek. However, they stressed the benefits of getting vaccinated against a virus that has killed over 1.4 million people worldwide and is still raging in many countries by far outweighs the risks.
Bill Moss is quoted.

12/04/20
Bloomberg

Andy Pekosz discusses he timeline for a rollout of a Covid-19 vaccine in the U.S. and adjusting coronavirus self-isolation guidelines.

12/04/20
C-SPAN
 [Video]
Experts say coronavirus vaccines need to be tested in children under 12 before they are rolled out. Pfizer has conducted some tests in children over 12 and Moderna expects to follow up with their own tests in that age group shortly
Bill Moss is featured.

12/04/20
C-SPAN
 [Video]
Johns Hopkins School of Public Health hosted a virtual press briefing with researchers and medical experts on COVID-19 vaccine distribution efforts. They provided a status update on the coronavirus vaccines recently announced by Pfizer, Moderna and AstraZeneca.
Bill Moss and Rupali Limaye are featured.

December 3, 220
WAMU

What should we be doing to protect ourselves during this precarious time? How much are cases rising locally? And how soon might a vaccine be available to you? In times of uncertainty, we look to medical professionals for guidance.
Bill Moss is interviewed.

December 3, 2020
AARP

Health experts say there is one thing that's critical for people to understand before they roll up their sleeves for the shots: While no major safety concerns have so far been reported, the vaccines may cause a few unwelcome side effects.
Bill Moss is quoted. 

December 3, 2020
TIME

This winter, the influenza virus has a rival—the coronavirus fueling the COVID-19 pandemic—and health officials are anticipating a showdown that could have dire consequences for the health of millions.
Andy Pekosz is quoted

December 3, 2020
The Washington Post

Ahead of the anticipated distribution of Moderna’s two-dose vaccine and a similar vaccine developed by Pfizer and German biotechnology company BioNTech, which could be coming in a matter of weeks, experts have stressed the importance of transparent messaging in ensuring wide public acceptance and completion of the vaccination regimens.
Bill Moss is quoted.

December 1, 2020
Popular Science

The past few weeks have been nothing but good news for COVID-19 vaccines. On Friday, Pfizer applied for emergency use authorization from the Food and Drug Administration (FDA) after announcing that its vaccine is 95 percent effective. Moderna isn’t far behind.
William Moss is quoted.

December 1, 2020
WPFW

William Moss discusses vaccine development and distribution as Moderna and Pfizer vaccines draw closer to becoming available.

November 30, 2020
WebMD

Pharmaceutical company Astra Zeneca will conduct more clinical trials to clear up questions about the effectiveness of its coronavirus vaccine
Andy Pekosz is quoted.

November 30, 2020
WHYY - NPR

Because it is such a resource- and labor-intensive containment tool, contact tracing in Philadelphia and the rest of Pennsylvania never ramped up to the levels recommended to effectively contain the coronavirus. The stretches when the city’s contact tracing resources could keep pace with the virus came only during the periods when there was minimal community spread.
Emily Gurley is quoted

November 30, 2020
BBC

Bill Moss discusses vaccine availability in Africa, estimating the vaccines won't be available to much of the continent until late 2021. 

November 30, 2020
Bloomberg

Andy Pekosz discusses confusion over the AstraZeneca Covid-19 vaccine trial and the rising number of hospitalizations in Europe.

November 25, 2020
Star Tribune

China says it has detected the coronavirus on packages of imported frozen food, but how valid are its claims and how serious is the threat to public health?
Andy Pekosz is quoted.

November 25, 2020
WMAR
 [Video]
It's been 10 months since the identification of COVID-19 and already, there are three vaccines with late-stage trials showing they are highly effective. Oxford-AstraZeneca is the latest, along with Pfizer and Moderna.
Bill Moss is featured.

November 25, 2020
Sinclair Broadcast Group [via WBFF]

Some nations have already rejected the idea of mandatory vaccinations. Much like lockdown mandates and stay-at-home orders that have been issued in the United States from the beginning of the COVID-19 pandemic, compulsory vaccination orders cannot be made by the federal government.
Joanne Rosen and Bill Moss are quoted.

November 25, 2020
The Associated Press

Don’t even think of putting the mask away anytime soon. Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the U.S. and Americans can once again go to the movies, cheer at an NBA game or give Grandma a hug.
Bill Moss is quoted.

November 24, 2020
1010WCSI.com

Following news of up to 90% coronavirus vaccine efficacy, AstraZeneca and Oxford University’s effort involves a more traditional method, as opposed to other vaccine candidate platforms. The Oxford-AstraZeneca vaccine involves an inactivated common cold virus isolated from chimpanzees, altered with genes to express the spike protein of the SARS-CoV-2 virus.
Bill Moss is quoted.

November 24, 2020
Sinclair Broadcast Group [via WBFF]

The method of vaccine development, first introduced as a concept in 1961, has been dubbed “revolutionary” by epidemiologists and has only been in serious development since the early 2010s when Moderna was formed. The COVID-19 pandemic pushed mRNA vaccine development into overdrive this year, fueled by government and private funding from across the globe.
Bill Moss is quoted.

November 24, 2020
Fortune

Positive results from these outpatient plasma trials could radically affect how quickly society and the economy return to normal—even as we wait for promising vaccines and drugs to be proven both “safe” and “effective,” the FDA’s standard for approval for broader use.
David Sullivan wrote the article.

November 24, 2020
FoxNews.com

Following news of up to 90% coronavirus vaccine efficacy, AstraZeneca and Oxford University’s effort involves a more traditional method, as opposed to other vaccine candidate platforms.
Bill Moss is quoted

Noveber 23, 2020
WBAL

Among the first of the questions that lie ahead for a potential coronavirus vaccine are who will get the vaccine and when? If all goes well, the first doses of a coronavirus vaccine could be available by the end of the year, according to a John Hopkins University expert. But that's where the questions start.
Bill Moss is featured.

November 23, 2020
Bloomberg

Andy Pekosz offers insight into emergency authorization of a vaccine as Pfizer Inc. and BioNTech SE plan to file Friday for use of their coronavirus vaccine in December.

November 19, 2020
WUSA

Both Pfizer and Moderna say they are close to a vaccine for COVID-19. In both cases, they are a type of brand new vaccine.
Bill Moss is featured.

November 19, 2020
TIME

Nothing about the current COVID-19 explosion should come as a surprise. As the virus spread throughout summer and fall, experts repeatedly warned winter would be worse. So it has. The U.S. is now locked in a deadly cycle of setting, then shattering, records for new cases and hospitalizations.
Bill Moss is quoted.

November 18, 2020
Newsweek

Moderna's COVID vaccine is easier to store, transport, and prepare than Pfizer's, experts have told Newsweek, giving it a "huge advantage" if and when the time comes for them to be rolled out across the U.S.
Bill Moss is quoted.

November 17, 2020
Bloomberg

Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns ��ѻ��ý, explains why gender is an important risk factor for Covid-19 and weighs on our progress toward a vaccine.

November 16, 2020
SELF

Measles infections worldwide have risen dramatically from their historic low in 2016, ringing alarm bells for public health experts around the globe. In 2019, the global death rate for measles was more than 50% higher than in 2016, and total cases increased by a whopping 556%, according to a joint report released by the Centers for Disease Control and Prevention and the World Health Organization.
Bill Moss is quoted.

November 16, 2020
Science News

Measles has come back with a vengeance around the world in recent years, wiping out steep declines in cases seen since the start of the new century.
Bill Moss is quoted.

November 16, 2020
TIME

Pfizer’s promising COVID-19 vaccine must be stored at about -70° C (-94° F)—a temperature cold enough to harden ice cream into a spoon-breaking block of ice, and that only specialized freezers can produce. Those cold storage requirements are raising serious questions about who could get the Pfizer vaccine if it’s approved, and when.
Bill Moss is quoted.

November 13, 2020
MarketWatch

Vaccines are a method of delayed antibody generation, and a vaccine for COVID-19 clearly would move us closer to resuming normal life. Except a vaccine represents just one approach to dealing with COVID-19 and, most likely, is not the panacea that we all long for.
David Sullivan wrote the piece.

November 13, 2020
Bloomberg

Andy Pekosz discusses hopes pinned on a Covid-19 vaccine, the Covid outbreak in Denmark’s mink population, and the reliability of coronavirus testing.

November 13, 2020
Bloomberg

William Moss, Executive Director of the International Vaccine Access Center at the Johns ��ѻ��ý, provides a coronavirus and vaccine update.

November 13, 2020
NBCNews.com

Research shows Covid-19 patients with life-threatening illness have antibodies that disable key immune system proteins called interferons.
Sabra Klein is quoted.

November 12, 2020
The Baltimore Sun

The freezers, which can hold about 4,000 doses each and cost between $10,000 and $20,000, are part of a larger, complex logistical distribution effort for potential vaccines from Pfizer or Moderna, which have both been tested in Maryland. But they represent among the biggest potential physical hurdles for distribution.
Andy Pekosz is quoted.

November 11, 2020
Scripps [via KRTV]
 
As of this week, we have optimistic news regarding phase-three efficacy results from biopharmaceutical company Pfizer – which has been collaborating with German company BioNTech.
Bill Moss is featured.

November 10, 2020
WMAR

On Monday night we were closer to a potential Coronavirus vaccine. Pfizer Incorporated and BioNTech announced they’ve created a vaccine that is 90% effective in preventing Coronavirus.
Bill Moss is featured.

November 6, 2020
Bloomberg

Andy Pekosz discusses the surge in U.S. coronavirus cases, hospitalization and mortality in the current wave of illness, and provides an update on coronavirus vaccine trials.

November 6, 2020
The New York Times

Scientists at Columbia University have developed a treatment that blocks the virus in the nose and lungs, is inexpensive and needs no refrigeration.
Arturo Casadevall is quoted.

November 3, 2020
NBCNews.com

Most experts agree that drops in antibody levels over time are expected, and that these declines are not altogether concerning.
Arturo Casadevall is quoted.

October 30, 2020
Bloomberg

Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns ��ѻ��ý, discusses why gender is an important a risk factor for COVID-19.

October 30, 2020
Bloomberg

Andy Pekosz discusses the increased rate of Covid infections as the weather turns cooler, acting to prevent hospitalizations, and what type of data we can expect from coronavirus vaccine trials.

October 29, 2020
WBAL

The Johns Hopkins University School of Medicine and the Bloomberg School of Public Health will create a new research center to study COVID-19 immunity. Researchers announced Wednesday that they received a five-year grant from the National Cancer Institute, which is part of the National Institutes of Health.
Sabra Klein is quoted.

October 29, 2020
The Baltimore Sun

Johns Hopkins researchers have launched a center to better understand how people’s immune systems respond to the coronavirus, information that could explain why some become more severely sick from COVID-19, the illness caused by the virus.
Sabra Klein is quoted.

October 28, 2020
WebMD

Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
Sabra Klein, study-lead, is quoted. 

October 23, 2020
STAT

The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease.
Arturo Casadevall is quoted.

October 23, 2020
Bloomberg
 [Video]
Andy Pekosz discusses realistic expectations for a coronavirus vaccine.

October 22, 2020
Voice of America

There won't be enough vaccinations for everyone at first. Hard decisions have to be made about who gets it and who doesn't. So, public health experts are laying out guidelines that aim to do the most good with a limited resource.
Bill Moss is quoted.

October 21, 2020
Cleveland.com

Older men who have recovered from COVID-19 coronavirus may be the best source of plasma containing antibodies that could help protect others from the disease, new research suggests.
Sabra Klein, study co-lead, is quoted.

October 21, 2020
CNBC.com

COVID-19 patients who are sick enough to be hospitalised are likely to have high levels of antibodies that can protect against the disease and maybe the best donors for convalescent plasma therapy, according to a study.
Sabra Klein, study co-lead, is quoted.

October 21, 220
CNN.com

Blood from the most severely ill Covid-19 patients may be the best for use in convalescent plasma therapy, according to a new study from Johns Hopkins University.
Sabra Klein, study co-lead, is quoted.

October 19, 2020
The Huffington Post

Early on in the pandemic, it became obvious that men – as well as older women – were more susceptible to negative outcomes from Covid-19. Men, especially, are more likely to be hospitalized by the virus and end up in intensive care. They are also twice more likely to die from the virus as women. It led researchers to hypothesize that the female sex hormone oestrogen might have some kind of protective effect.
Sabra Klein is quoted.

October 19, 2020
Bloomberg

Andy Pekosz says it's "quite clear" wearing masks reduces cases of Covid-19 infections and will help prevent an economic lockdown.

October 16, 2020
Gray TV DC

The United States military fights terrorism, saves lives during natural disasters, and now, its latest mission is the war on coronavirus. This is the biggest role the military has ever played in preparing for vaccine distribution to the public. And it is also the most ambitious timeline for developing, manufacturing, and delivering a vaccine.
Bill Moss is featured.

October 15, 2020
Bloomberg

William Moss discusses ways to safely accelerate the coronavirus vaccine development process, challenges in delivering a vaccine to patients, and the differences between antibody treatments and a vaccine.

October 14, 2020
ABCNews.com

Several states have curtailed using coronavirus testing equipment in nursing homes that was provided by the Trump Administration after concerns were raised about the results, including false positives that risk mistakenly sending vulnerable seniors into special COVID isolation wings that could ultimately expose them to the virus.
Emily Gurley is quoted.

October 12, 2020
NHK World - Japan

Many countries are rushing to secure COVID-19 vaccines for their own population's use, and wealthy nations are funding research to procure massive amounts of doses. Some developing countries are trying to secure vaccines, which may not yet be proven safe, raising concerns that there will be discrepancies in vaccine distribution. Should the most vulnerable people and countries have early access to vaccines?
Bill Moss is featured.

October 12, 2020
NPR

That "15-minute rule" is the Centers for Disease Control and Prevention's guideline for defining a close contact of an infected person. But experts say the risk of infection is a lot more nuanced than that guidance might imply.
Emily Gurley is quoted.

October 5, 2020
Maryland Public Television
 [Video]
Andy Pekosz is featured at the 1:50 mark.

October 5, 2020
People Magazine

Emily Gurley is quoted.

October 5, 2020
Newsweek

Bill Moss is quoted.

October 2, 2020
Brown Daily Herald

Researchers at Rhode Island Hospital and Johns Hopkins University study the efficacy of potential COVID-19 treatment for early stages of illness.
David Sullivan is quoted.

October 2, 2020
CGTN
 [Video]
Coronavirus deaths worldwide are near 1 million, most of them here in the United States: more than 2 hundred thousand lives lost. And the outlook is dire for the country: COVID-19 infections rose in 21 states last week. It could impact schools reopening and the easing of restrictions.
Bill Moss is featured.

October 2, 2020
WIRED

On Thursday, Mikie Sherrill, a freshman congressperson from New Jersey, plans to introduce the SPEEDY Act, which would tie federal reimbursement to test result speeds.
Emily Gurley is quoted.

October 2, 2020
Bloomberg

Andy Pekosz discusses President Donald Trump testing positive for Covid-19 and the potential issues he faces as part of a high-risk group.

October 1, 2020
NHK
 [Video]
As the coronavirus pandemic still sweeps around the world with second waves already erupting in some countries, pharmaceutical companies and research institutes around the world are fast-tracking the development of COVID-19 vaccines. Some scientists say that vaccine trials and approvals take months or even years. However, US President Trump claims one will be available before the presidential election. So, when will we have a safe and effective vaccine?
Bill Moss is featured.

September 28, 2020
KUSI News
 [Video]
Two COVID-19 clinical trials are currently being conducted locally at UC San Diego and there is an urgent need to find participants. 
David Sullivan is featured.

September 28, 2020
The Hub

In 'The Wall Street Journal', Johns Hopkins immunologist Arturo Casadevall explains the different federal responses to the COVID-19 treatment and why it's normal to lack consensus in science
Arturo Casadevall is mentioned.

September 25, 2020
Nature

Plasma from individuals who have recovered from COVID-19 could benefit sick patients, but definitive evidence for or against convalescent plasma is still lacking.
Arturo Casadevall is quoted.

September 25, 2020
Bloomberg

Andy Pekosz discusses the varying effects of coronavirus on different patients, studies on mutations in the virus, and what is to be expected of a successful vaccine.

September 24, 2020
UPI

Becoming ill with both COVID-19 and the seasonal flu is possible, but it's unclear whether one virus makes the other one worse, experts said this week.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
WebMD

While all 50 states and the District of Columbia have COVID-19 data dashboards, the data reported is inconsistent, incomplete, and inaccessible in most locations, a report from Resolve to Save Lives concludes.
Andy Pekosz and Dan Salmon are quoted

September 24, 2020
Route Fifty

The symptoms of the flu and coronavirus are similar and experts warn confusion over the two could overburden Covid-19 testing capacity.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
Newsy

Symptoms for COVID-19 and the flu are almost identical, like body and muscle aches. One major difference, COVID-19 patients often lose smell or taste. The same people are at high risk for both.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
Roll Call

A rough flu season could compound the problems the COVID-19 pandemic has already caused in the United States, and public health experts are warning that a mild flu season in the Southern hemisphere may not mean Americans will experience the same thing.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
The Hill 

After surpassing another grim milestone — 200,000 confirmed coronavirus deaths — the U.S. is bracing for an increase in lives lost this fall and winter as the pandemic collides with flu season.
Andy Pekosz is quoted.

September 24, 2020
Bloomberg
 [Podcast]
Andy Pekosz discusses the U.S. response to the coronavirus pandemic as the country surpasses 200,000 deaths.
He is featured at the 15:40 mark.

September 23, 2020
Boston Herald 

The impending flu season coupled with the ongoing coronavirus pandemic could make for an even greater public health challenge this winter, burdening testing capacity and hospitals, according to Johns Hopkins experts.
Andy Pekosz and Dan Salmon are quoted.

September 23, 2020
News 12 - Westchester

As the weather gets colder, Americans are facing another viral threat: the flu.Doctors at the Johns ��ѻ��ý say social distancing and wearing masks will help people avoid the flu, as well as the coronavirus. Andy Pekosz is featured.

September 23, 2020
WBFF

Doctors are worried about a possible 'twindemic' this fall, warning of what could happen when flu season and COVID-19 overlap.
Andy Pekosz and Dan Salmon are featured.

September 23, 2020
WMAR

Just in time for the start of fall, health officials at Johns Hopkins University are warning the public to be aware of the so-called “twin-demic” of the flu and the coronavirus.
Andy Pekosz and Dan Salmon are featured.

September 23, 2020
WJZ
 
COVID-19 has now killed more than 200,000 people in the US. Johns Hopkins doctors are worried about a double hit with the flu this fall.
Andy Pekosz and Dan Salmon are featured. 

September 23, 2020
WTOP

Health experts from Johns Hopkins University in Baltimore are warning of a flu and coronavirus “twin-demic,” and they are urging people to get their flu shots so as not to overwhelm an already stetched-out health care system. Andy Pekosz and Dan Salmonare quoted.

September 23, 2020
Business Insider 

A shortage of a chemical used to process the COVID-19 test has caused healthcare systems across the US to limit who is able to get a test — right before the start of the flu season — The Wall Street Journal reported.
Andy Pekosz and Amesh Adalja are quoted.

September 23, 2020
The Guardian 

A national public health campaign promoting the flu vaccine is urgently needed to avoid stretched healthcare services being overwhelmed this winter as the US faces cold season while still struggling to gain control of the coronavirus pandemic, scientists have warned.
Dan Salmon and Andy Pekosz are quoted.

September 23, 2020
CBSNews.com

As much of America enters its seventh month of quarantine measures, more than 200,000 people have died from the coronavirus, and the mental and financial health of the country is wearing thin. Hopes of returning to normalcy are now pinned on one thing: finding a vaccine.
Bill Moss is quoted.

Septmember 23, 2020
The Wall Street Journal

How can two federal agencies come to different conclusions on a topic of such great importance in the middle of an epidemic? Understanding the dispute requires a little history and also thinking about how experts evaluate evidence.
Arturo Casadevall coauthored the piece

September 21, 2020
Fox19 - Cincinnati

A study of two new possible treatments for COVID-19 from Johns Hopkins University and University of Cinncinnati's College of Medicine will use convalescent blood plasma to test its effectiveness as outpatient therapy. The trial will help determine whether antibodies from people who have recovered from COVID-19 can help those who have been recently exposed or have been recently been diagnosed and have symptoms.
David Sullivan is featured.

September 21, 2020
WJAR - Rhode Island
 
Researchers worked to prevent the progression of COVID-19 early on. Rhode Island Hospital is one of 30 test sites nationally. This research centers around using a century-old technology: convalescent plasma. Right now, it’s being used as a treatment in the hospital setting for some of our sickest COVID-19 patients.
David Sullivan is featured.

September 21, 2020
WCVB5 - Worcester
 
A nationwide COVID-19 study that is looking at infection prevention and curative early treatment is now underway, and researchers in Worcester are looking for your help.
David Sullivan is featured.

September 21, 2020
The Baltimore Sun

Johns Hopkins University is seeking Baltimore- and Annapolis-area residents who recently have been diagnosed with or exposed to the coronavirus for two clinical trials studying the effectiveness of blood plasma with virus antibodies in preventing and treating infections of COVID-19.
David Sullivan is mentioned.

September 18, 2020
KJZZ

Around the globe, labs and factories are racing to test and produce more than a billion doses of coronavirus vaccine.To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods.
Bill Moss is interviewed.

September 18, 2020
Bloomberg

Andy Pekosz discusses the ebb and flow of covid-19 in the United States as the nation nears 200,000 virus deaths and steps to try to avoid a second wave of infections.

September 17, 2020
Sharecare

Are COVID-19 survivors really at risk of getting it again? The answer to that question isn’t clear—at least not yet. There is no definitive proof that recovering from COVID-19 and producing antibodies to SARS-CoV-2 means people won’t get the disease a second time. David Sullivan is quoted.

September 17, 2020
WMAR

With the uncertainty of what fall will bring, researchers are working hard to find a solution for COVID-19.
David Sullivan is featured.

September 16, 2020
The Scientist

The US Food and Drug Administration (FDA) recently granted emergency use authorization (EUA) for its use, although the absence of randomized controlled trials (RCTs) has led to skepticism about its effectiveness among experts.
Arturo Casadevall is quoted. 

September 15, 2020
NPR
 [Radio]
When a safe and effective COVID-19 vaccine becomes available, it's a complex process to distribute it and make it accessible to everyone who needs it.
William Moss is interviewed.

September 14, 2020
Bloomberg
 [Video]
Andy Pekosz discusses the pause of AstraZeneca’s phase three vaccine trial, new information on children and Covid-19, and how colleges and universities are handling coronavirus outbreaks.

September 10, 2020
C-SPAN
 [Video]
William Moss, executive director of the Johns ��ѻ��ý International Vaccines Center, talks about the national and international effort to develop a COVID-19 vaccine.

September 9, 2020
Forbes

For high achievers, it’s not a question of if they will get through the latest hiccup, as they have confidence that they will. The question for them is how and when.
Peter Agre is quoted.

September 8, 2020
The Washington Post

Deer mice, the most abundant mammal native to North America, can catch the coronavirus and pass it to other mice in laboratory settings, raising a remote possibility that they could become a reservoir for the pathogen in nature and transmit it to humans.
Sabra Klein is quoted.

September 8, 2020
The Baltimore Sun

Gov. Larry Hogan announced this week that the state would adopt the tech giants’ jointly developed software, Exposure Notification Express, or ENX, which uses smartphones to alert users if they have had contact over the past 14 days with someone who has tested positive for the virus.
Emily Gurley is quoted.

September 8, 2020
Radiolab

Six years ago, a new infection began popping up in four different hospitals on three different continents, all around the same time. It wasn’t a bacteria, or a virus. It was ... a killer fungus. No one knew where it came from, or why. Arturo Casadevall is featured.

August 28, 2020
The Washington Post

A shift this week in government testing guidelines for Americans exposed to the novel coronavirus was directed by the White House’s coronavirus task force, alarming outside public health experts who warn the change could hasten the disease’s spread.
David Sullivan and Jennifer Nuzzo are quoted.

August 27, 2020
The New York Times

The coronavirus may infect anyone, young or old, but older men are up to twice as likely to become severely sick and to die as women of the same age. Why? The first study to look at immune response by sex has turned up a clue:
Sabra Klein is quoted

August 26, 2020
USA Today

Four months after Apple and Google announced an unusual collaboration to help public-health authorities track the novel coronavirus, apps built on their privacy-optimized Exposure Notification framework have begun arriving in the U.S.
Emily Gurley is quoted.

August 26, 2020
The Huffington Post

For the last few weeks, the FDA has been wrestling with whether to authorize plasma therapy on a nonexperimental basis, which would mean doctors could prescribe it on the spot.
Arturo Casadevall is quoted.

August 25, 2020
Healio

The FDA authorized the emergency use of convalescent plasma as a therapy for patients hospitalized with COVID-19, saying the “known and potential benefits” of the technique outweigh any risks. However, others questioned the timing of the emergency use authorization (EUA) while trials assessing convalescent plasma for COVID-19 therapy are ongoing.
Arturo Casadevall is quoted.

August 25, 2020
Science Magazine

The authorization for convalescent plasma could allow more hospitalized patients to receive the antibody-rich plasma, which is donated by people who have recovered from the disease. But in the wake of Trump’s announcement, which came a day before the start of the Republican National Convention, researchers struggled to sort the politics from the medical and scientific import of the EUA.
Arturo Casadevall is quoted.

August 25, 2020
The New York Times

Experts discuss a statistic used by administration officials when announcing the FDA's emergency use authorization for convalescent plasma treatment. The number has no clear origin.
Arturo Casadevall is quoted.

August 25, 2020
ABCNews.com

In the high-pressure push to combat COVID-19, two things have become abundantly clear: we need effective treatment and we need further data to inform our findings.
Arturo Casadevall is quoted.

August 25, 2020
Bloomberg

The head of the U.S. Food and Drug Administration has reversed the claim that an experimental therapy had provided a dramatic benefit to Covid-19 patients. “What I should have said better is that the data show a relative risk reduction not an absolute risk reduction,” said Stephen Hahn.
Arturo Casadevall is quoted.

August 24, 2020
The Washington Post

Arturo Casadevall discusses the importance of the FDA support for emergency authorization use of convalescent plasma as a treatment against the coronavirus.

August 24, 2020
NPR
 [Radio]
Arturo Casadevall discusses the importance of convalescent plasma treatment and early promising results in advance of clinical trials.

August 20, 2020
WBAL

A new test is now available that allows people to swab for the coronavirus on surfaces in public places. This technology could help determine whether schools and businesses are doing a good job of disinfecting.
Andy Pekosz is featured.

August 20, 2020
Scientific American

What determines if someone gets desperately ill from the disease that is ripping its way across the planet? You are likely familiar with the broad categories of people who face greater risk: older individuals, men, those who have certain chronic conditions, and in some countries people of color. Researchers are looking deeper into these groups to determine the underlying roots, both biological and social, for their vulnerability.
Sabra Klein, Sherita Golden and Erin Michos are quoted.

August 18, 2020
CNN.com

President Donald Trump and US health leaders have done a full court press to encourage people who survived Covid-19 to donate plasma to help those who are sick.
Arturo Casadevall is quoted.

August 17, 2020
The Associated Press

Comparing U.S. state and city contact tracing programs is difficult because they vary widely in what they release, but some public health scholars say the numbers that New York reports are promising.
Emily Gurley is quoted.

August 17, 2020
Gizmodo

A vaccine for the coronavirus that causes covid-19 appears to be our best strategy to ending the current pandemic. Unfortunately, the fastest time frame in which scientists have managed to create any vaccine in history was four years, and there’s already plenty of skepticism surrounding the safety, availability, and effectiveness of any future covid-19 inoculation.
William Moss is quoted. 

August 14, 2020
Bloomerg 

Andy Pekosz discusses the possibility of Covid-19 reinfection, coronavirus transmission, and concerns about valve masks.

August 11, 2020
The Scientist
 The Johns Hopkins University researcher bucked the prevailing idea that the body would not launch an immune response against its own tissues, and in doing so established an entirely new scientific discipline.

August 10, 2020
Bloomberg
 [Video]
Andrew Pekosz discusses questions surrounding the return of children to school and looks at phase three vaccine trials.

August 10, 2020
Wired

With infections rampant in parts of the nation, backlogs are preventing people from getting timely test results, hampering efforts to contain the virus.
Emily Gurley is quoted.

August 10, 2020
Buzzfeed News

As we await a coronavirus vaccine, the spotlight in COVID-19 treatments is returning to antibodies, the body’s natural defenses against viruses. While almost no US hospitals were using convalescent plasma treatment before April, it is now administered to an estimated 1,500 patients a day in around 2,000 hospitals nationwide.
Arturo Casadevall is quoted.

August 5, 2020
The New York Times

American scientists are hoping Covid-19 patients in Brazil will help them answer a century-old question: Can this golden serum, loaded with antibodies against a pathogen, actually heal the sick?
Arturo Casadevall is quoted.

August 4, 2020
Associated Press

Gone for now are the days of baseball players, often dirt-stained and still in uniform, gathering in the clubhouse to scarf down a late night meal before heading their separate ways until doing it all again some 24 hours later. Emily Gurley is quoted. 

August 4, 2020
CNN.com

A recently published summary article in the journal Nature Reviews Immunology put forth a tantalizing possibility: A large percentage of the population appears to have immune cells that are able to recognize parts of the SARS-CoV-2 virus, and that may possibly be giving them a head start in fighting off an infection. In other words, some people may have some unknown degree of protection.
Arturo Casadevall is quoted.

August 3, 2020
The Los Angeles Times
Amid a pandemic response that promises marvels of genetic engineering, vaccines developed at “warp speed” and artificial intelligence at the bedside, it takes courage for a scientist to dust off a remedy from the history books and propose it as modern medicine.
Arturo Casadevall is quoted.

August 3, 2020
Voice of America
Researchers are testing a fungus known to grow in high radiation environments to see if it could possibly protect humans traveling in space. One fungus being studied survived – even thrived – in areas around the former Chernobyl nuclear power center in Ukraine.
Radamés J.B. Cordero is quoted. 

August 3, 2020
Associated Press

After 20 years in baseball ranging from media relations to international scouting, Moisés Rodríguez is in a role he never imagined — contact tracer during a coronavirus pandemic.
Emily Gurley is quoted. 

July 31, 2020
NBC News

Factors such as testing delays, distrust and embarrassment are combining to make efforts to contain COVID-19 more difficult in the state that now has the highest number of cases in the nation.
Emily Gurley is quoted.

July 30,2020
Healthline

Three more COVID-19 investigational vaccines have been shown in early clinical trials to be generally safe and to induce an immune response in healthy volunteers.The results of two of these studies were published online yesterday in The Lancet. One is a phase 1 and 2 trial by researchers at Oxford UniversityTrusted Source with support from AstraZeneca. The other is a phase 2 trial by Chinese researchers supported by CanSino BiologicsTrusted Source.
Naor Bar-Zeev and William Moss, who coauthored an  cited in the article, are quoted. 

July 27, 2020
Bloomberg
 [Video]
Andy Pekosz discusses the severity of Covid-19 infections and how they appear to be less severe in individuals under the age of ten.
He is featured around the 1:57:40 mark

July 24, 2020
Fox 8
 [Video]
With no COVID-19 vaccine approved yet, there is a lot of focus on antibodies, proteins that develop after someone has been infected with the virus. Antibodies are supposed to help fight off infection and provide protection against re-infection. But UCLA research published this week in the New England Journal of Medicine found that in some people the antibodies disappeared or decayed quickly. Arturo Casadevall is featured.

July 22, 2020
Physician's Weekly

As the Covid-19 pandemic rages on, the race for a vaccine is heating up. On Monday, July 20, promising early results of three vaccine trials were announced, two published in The Lancet — one from the University of Oxford and AstraZeneca, and the other from CanSino Biologics — and the third, from Pfizer and BioNTech, published by medRxiv, the results of which have not yet been peer reviewed.  William Moss and Naor Bar-Zeev, who coauthored an  cited in the article, are quoted.

July 22, 2020
The Hill 

On Monday, the medical journal The Lancet published two studies about two promising vaccine candidates. The Oxford University group based at Jenner Institute tested their vaccine on more than 1,000 people. A biotech group in China called CanSino tested their vaccine on about 500 participants.
William Moss and Naor Bar-Zeev, who coauthored an  cited in the article, are quoted. 

July 22, 2020
Scientific American

Across the U.S., states that once acted as if the pandemic was going away are setting new daily records for infections, hospitalizations and deaths. There is one proved tool that has helped other countries stem the pandemic -- contact tracing. But in the U.S. it is severely underused.
Emily Gurley is quoted.

July 22, 2020
CNN

Results from trials involving three different coronavirus vaccines released Monday, all showing positive results, with evidence the vaccines can produce immune responses that would be expected to protect people against infection.
William Moss and Naor Bar-Zeev, who coauthored an  cited in the article, are quoted.

07/20/20
Bloomberg [Video]

Andrew Pekosz discusses the surge in U.S. coronavirus cases, and how the virus is impacting younger individuals.

July 17, 2020
Bloomberg [Video]

Andrew Pekosz discusses the surge in U.S. coronavirus cases, and how the virus is impacting younger individuals.

July 14, 2020
Bloomberg [Video]

Arturo Casadevall discusses his latest work and the impact of convalescent plasma in the fight against Covid-19. 

July 13, 2020
Boston Globe [Paywall]

Three months after the death tolls reached their devastating peaks, the two unions are charting increasingly divergent paths. Europe is recovering, swiftly and definitively, while the United States stalls and splinters.
Bill Moss is quoted.

July 10, 2020
CBS This Morning

Researchers have been studying the effects of the coronavirus on both men and women, and they've found that men are more likely to suffer worse outcomes from the disease, and are as much as 2.4 times more likely to die. Sabra Klein is featured.

July 8, 2020
USA TODAY

Just as everyday life has been affected by COVID-19, science itself has changed. Scientists have had to learn how to produce meaningful information for a world clamoring for speedy results. 
Arturo Casadevall is quoted.

July 1, 2020
Bloomberg
 [Video]
Andrew Pekosz discusses the surge in U.S. coronavirus cases, and what is being learned about how the virus works within the human body.

June 22, 2020
BBC

New research by a group of scientists in India and US shows that although men make up the majority of infections, women face a higher risk of dying from the coronavirus than men.
Sabra Klein and Kunihiro Matsushita are quoted.

June 15, 2020
The Hill

If serology test results are to be used in public health decision making—such as reporting the true prevalence of a disease or changing reported case fatality rates — the tests used must be as dependable as possible.
Gigi Gronvall and Rachel West wrote the article

June 15, 2020
Bloomberg
[VIDEO] 
Reopening economies too early risks a fast rebound of infections
Andrew Pekosz is interviewed.

June 15, 2020
National Geographic

Researchers are narrowing down how long the virus persists inside the body and whether people can be quickly re-infected.
Diane Griffin is quoted.

June 11, 2020
Bloomberg
 [Audio]
Protests over the past week have raised concerns over the possibility of a spike in coronavirus cases, and mixed messaging on how COVID-19 spreads has created nationwide confusion.
Andy Pekosz is introduced at the 14:30 mark

June 11, 2020
NPR – Goats and Soda

When the new coronavirus started spreading around the world, there were dire warnings about what would happen when it hit African countries. Now, there are a range of predictions – from pessimistic to guardedly optimistic.
Shaun Truelove and William Moss are quoted.

June 8, 2020
Bloomberg
 [Video]
Andrew Pekosz updates work on vaccines and antibody treatments for Covid-19 and examines the spread of the virus as public restrictions are loosened in the United States.

June 5, 2020
WebMD

The blood plasma of people who have recovered from the new coronavirus infection may help critically ill COVID-19 patients recover, a new study finds.
Arturo Casadevall is quoted.

June 4, 2020
U.S. News & World Report

The blood plasma of people who have recovered from the new coronavirus infection may help critically ill COVID-19 patients recover, a new study finds.
Arturo Casadevall is quoted.

June 2, 2020
Los Angeles Times

David Sullivan usually studies malaria in remote regions of Bangladesh and Africa. That work has made him an expert on the drug chloroquine, which showed apparent promise as a COVID-19 treatment in the outbreak’s earlier days. But after his colleagues at Johns Hopkins University pulled him into COVID-19 discussions, he noticed a research gap in a very different part of the pandemic fight: convalescent plasma.

June 2, 2020
Consumer Reports

What was long thought of as “normal” is not coming back anytime soon. But after the current phase of lockdown ends, there will be a new normal—less restrictive than simple stay-home orders, but far different from what we knew before.
William Moss and Crystal Watson are quoted.

May 29, 2020
Bloomberg
 [Video]
Andrew Pekosz discusses antibody testing and wearing masks as part one of protection against Covid-19.

May 28,2020
USA TODAY

Two new clinical trials will begin this week testing plasma from patients who have recovered from COVID-19 on people who have been exposed to the virus, or are in the early stages of the disease.
Arturo Casadevall is quoted.

May 26, 2020
Bloomberg
 [Video]
Andrew Pekosz discusses the rising concern over the spread of the coronavirus in Latin America and Africa

May 15, 2020
Bloomberg
 [Video]
Andrew Pekosz discusses taking a different approach to Covid-19 testing and monitoring as economies begin to reopen.

May 13, 2020
U.S. News & World Report

Could blood plasma drawn from people who've recovered from COVID-19 help prevent new coronavirus infections or ease symptoms in those already infected?
Arturo Casadevall is quoted.

May 12, 2020
VOA

Twenty-year-old Leo Canty says he was worried less about himself and more about the people around him when he tested positive for COVID-19. The college student was determined to donate his plasma for potential therapy for both prevention and treatment in the fight against the coronavirus.
Arturo Casadevall is quoted.

May 11, 2020
The Wall Street Journal
 [Paywall]
A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding goal for researchers, is less important than the old-fashioned public health measures being used against the pandemic.
Arturo Casadevall is featured.

May 11, 2020
Bloomberg
 [Video]
Relentless work is being done on finding a coronavirus vaccine, and now mobile apps will be used to conduct contact tracing.
Andrew Pekosz is interviewed.

May 11, 2020
The Baltimore Sun

A donation program, part of an initiative at LifeBridge Health, is joining numerous hospitals and universities around the country in exploring the use of convalescent blood plasma as a therapy for people suffering from COVID-19.
Arturo Casadevall and David Sullivan are quoted.

May 11, 2020
CBS News

Convalescent plasma may just be a stop-gap measure against COVID-19 until more treatments and a vaccine come along. But doctors have already used donated plasma on thousands of patients, and are finding some success with a procedure that dates back more than 120 years.
Arturo Casadevall is featured.

May 11, 2020
Healio

Two randomized, placebo-controlled clinical trials at Johns Hopkins Medicine aim to determine whether blood plasma will be effective as prophylaxis against COVID-19, a strategy that would be “enormously valuable” and has been efficacious against other viral diseases.
Arturo Casadevall is quoted.

May 7, 2020
WBAL TV 11 - NBC

Pediatricians around Maryland are growing more and more concerned as more parents are canceling well-child checkups and vaccinations out of fear of becoming infected with coronavirus.
William Moss is quoted.

May 5, 2020
Business Insider

Researchers fear the current pandemic could only be the beginning of a new battle against infectious disease outbreaks—the World Health Organization warns that climate change could make the spread of disease even worse in the coming decades.
Arturo Casadevall is quoted.

May 5, 2020
Bloomberg
 [Video]
Andy Pekosz discusses testing of existing medicines as coronavirus treatments, and the importance of antibody research and testing.

May 5, 2020
Bloomberg
 [Podcast]
Andy Pekosz joins the show at the 27:55 mark.

April 30, 2020
Inverse

"Being male is a risk factor for death from Covid-19."
Sabra Klein is quoted.

April 30, 2020
FiveThirtyEight

While men account for the majority of COVID-19 cases in some countries but a minority of cases in others, they consistently make up the majority of deaths.
Sabra Klein is featured.

April 28, 2020
WebMD

Antibody testing has the potential to help determine when Americans can return to work and resume normal activities, as well as who can donate blood that can be used to make convalescent plasma to help those who are gravely ill.
Diane Griffin is quoted.

April 28, 2020
National Geographic
 [Paywall]
Here are some of the coronavirus therapies currently being tested, with estimates of how soon they might be widely available for the general public.
Arturo Casadevall is quoted.

April 28, 2020
Maryland Public TV – Direct Connection
 [Video]
When host Jeff Salkin talked to the show’s first coronavirus expert, from the Johns ��ѻ��ý, Maryland had 0 reported cases. 8 weeks later, over 800 people have lost their lives statewide, and over 1,500 are currently hospitalized.
Andy Pekosz rejoins the show.

April 27, 2020
The New York Times
 [Paywall]
Men are more likely than women to die of the coronavirus, so scientists are treating them with something women have more of: female sex hormones.
Sabra Klein is quoted.

April 27, 2020
CBS News

Some medical experts interviewed by CBS News question some of the administration's claims about whether China's lack of transparency is actually blocking the world from developing a vaccine.
Andrew Pekosz is quoted.

April 24, 2020
NPR

Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women.
Research led by Sabra Klein is mentioned.

April 24, 2020
Bloomberg
[Video] 
Explaining distinctions between topical and internal virus treatments, and the timeline for vaccine testing.
Andrew Pekosz is featured.

April 22, 2020
FOX 17 – Nashville

What if you could one day get coronavirus protection without a shot? One research team in Pittsburgh is working on a small skin patch it says has the potential to stick it to the coronavirus in an innovative way.
William Moss is featured.

April 21, 2020
GQ

While many mysteries remain, one attribute of the virus that has become clear is that more men than women are dying of Covid-19, the infectious disease that coronavirus can cause in humans.
Sabra Klein is quoted.

April 20, 2020
TIME

A California doctor accused of hawking a supposed “miracle cure” for COVID-19 is facing up to 20 years in prison for fraud.
David Sullivan is quoted.

April 17,2020
Bloomberg
 [Video]
Andy Pekosz explains what is being learned about patterns of coronavirus infections, the uncertainties of testing, and questions about immunity and reinfection.

April 17,2020
WBAL TV 11

It's been more than a month since the coronavirus pandemic hit Maryland, but medical experts don't expect a peak to hit until sometime next in May.
William Moss is quoted.

April 17,2020
Newsweek
 [Opinion]
In the current COVID-19 pandemic, both China and Italy have used convalescent plasma as a treatment, and the emerging data is encouraging.
Arturo Casadevall is mentioned.

April 16,2020
Mother Jones

Kellie Burns, a former health care consultant who’d been tuning into New York Gov. Andrew Cuomo’s daily coronavirus briefings, had determined that an experimental transfusion of convalescent plasma was the least risky, most feasible option to give her father a fighting chance in his battle with the coronavirus.
Arturo Casadevall is quoted.

April 14, 2020
Bloomberg
 [Audio]
Andy Pekosz discusses tracking the path at the coronavirus outbreak.
He is introduced to the podcast at the 1:50 mark

April 13, 2020
Politico

Most of us have made huge changes in our lives over the past month and are facing an uncertain future, all while trying to wrap our heads around a global health and economic mess.
Sabra Klein is featured.

April 13, 2020
Yahoo! News

In a study of over 2,500 children—aged 0 to 18—with COVID-19, some 57 percent were male, suggesting that “biological factors” could make men more susceptible to the virus.
Sabra Klein is quoted.

April 8, 2020
International Business Times

There is little scientific evidence on the efficacy of an anti-malarial drug combination to fight COVID-19. State officials, however, are banking their hopes on a small study showing that the drug may have helped a small group of patients who were mildly ill from COVID-19 to recover.
David Sullivan is quoted.

April 7, 2020
Bloomberg
 [Opinion]
Although the initial epidemiological data show that Covid-19 is more severe in older people, men and those with pre-existing conditions, not everyone with severe disease has these risk factors. And not everyone at risk has the same symptoms, prognosis or outcome.
Arturo Casadevall co-wrote the piece.

April 6,2020
The Washington Post
 [Paywall]
An emerging body of research has revealed that women’s bodies are better at fighting off infection, thanks to the hormones in their systems and the genes on their two X chromosomes.
Sabra Klein is quoted

April 6, 2020
New York Post

Researchers at Johns Hopkins University now have federal approval to test if blood plasma from recovered COVID-19 patients can help protect the heroes on the front line of the battle against coronavirus.
Arturo Casadevall has amassed a team of physicians and scientists from around the country who are now establishing a network of hospitals and blood banks that can collect, isolate and process blood plasma from COVID-19 survivors.

April 6, 2020
The New York Times
 [Paywall]
Data from other countries shows that more men are dying from the virus than women — a discrepancy that should inform the response and vaccine research in the U.S. But it isn’t.
Sabra Klein is quoted.

April 6, 2020
The New York Times
 [Paywall]
President Trump said on Friday that the Centers for Disease Control and Prevention was urging all Americans to wear a mask when they leave their homes, but he immediately undercut the message by repeatedly calling the recommendation voluntary and saying that he would not wear one himself.
Sabra Klein is quoted.

April 3, 2020
The Wall Street Journal
 [Paywall]
A national Covid-19 project seeks volunteers to aid the seriously ill.
Arturo Casadevall is featured.

April 2, 2020
USA Today

Whether the plasma, derived from the blood of people who have recovered from COVID-19, will help them fight off the devastating disease is still unknown. But in less than 3 weeks, the effort to find out has gone from an idea to a worldwide program entirely self-organized by medical researchers.
Arturo Casadevall is quoted

April 1, 2020
France24

As the world faces the most serious public health crisis in a century, scientists and professionals are scrambling to understand who is most vulnerable to Covid-19 and why.
Sabra Klein is quoted.

March 30, 2020
Buzzfeed

This week, researchers in New York City started collecting blood from COVID-19 survivors. The hope is that their immunity can be shared with others.
Arturo Casadevall is quoted.

.March 30 2020
The Washington Post

Plasma is being studied as a way to fight off the virus
Arturo Casadevall and Evan Bloch are quoted

March 27, 2020
The Washington Post
 [Paywall]
Pneumonia cases, hospitalizations, ICU visits, death and even basic symptoms were more frequent in males.
Sabra Klein is quoted.

March 26, 2020
NPR

The FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections.
Arturo Casadevall, who co-championed the idea, is featured.

March 26, 2020
Nature

Hospitals in New York City are gearing up to use the blood of people who have recovered from COVID-19 as a possible antidote for the disease.
Arturo Casadevall who has been fighting to use blood as a COVID-19 treatment since late January, is featured.

March 26, 2020
The Guardian

Behavioural factors that differ across genders may have a role in fatality rates of the coronavirus. However, there is a growing belief among experts that more fundamental biological factors are at play.
Sabra Klein is quoted.

March 24, 2020
NBC News

Hoping to stem the toll of the state’s surging coronavirus outbreak, New York health officials plan to begin collecting plasma from people who have recovered and injecting the antibody-rich fluid into patients still fighting the virus.
Arturo Casadevall is quoted

March 23, 2020
The Washington Post
 [Paywall]
A growing number of universities are suspending nonessential research, another sign of the vast disruption the pandemic is wreaking, with faculty members and graduate students racing to close labs.
Arturo Casadevall is quoted.

March 23, 2020
Forbes

Given the life and death situation of hospitalized patients with COVID-19 and the possibility that hydroxychloroquine plus azithromycin may be helpful, it is valuable and ethical for authors of drug-testing studies to report results.
Ying Zhang is quoted

March 20, 2020
The Washington Post

Upwards of 70 percent of deaths in Italy have been men. The question is: Why?
Sabra Klein is quoted.

March 20, 2020
Fox News

More than 10,000 people have died from the novel coronavirus, with men seemingly hit harder by the virus than women, according to early data.
Sabra Klein is quoted.

March 19, 2020
Milwaukee Journal Sentinel (USA Today Network)

The Johns Hopkins University doctor coordinating a nationwide effort to launch emergency clinical trials of plasma from patients who've recovered from coronavirus said he expects to forward a plan to the U.S. Food & Drug Administration Wednesday and to start treating the first patients in about four weeks.
Arturo Casadevall, who has been organizing the convalescent sera efforts nationwide, is quoted.

March 18, 2020
The Baltimore Sun

As much of Maryland and the United States hunker down at home to help stop spread of the coronavirus, scientists are making progress in understanding how the virus is transmitted, how it affects humans and, most importantly, how it can be stopped.
Experts at the Johns ��ѻ��ý offered some updates and things people can do now. This Q&A is adapted from a webcast moderated by Dr. Joshua Sharfstein, and includes Andy Pekosz and Caitlin Rivers.

.March 17, 2020
The New York Times
 [Paywall]
Public health officials say a coronavirus vaccine won’t be ready for widespread public use for at least a year to 18 months, taking us well into 2021.
Andrew Pekosz is mentioned.

March 16, 2020
Forbes

How bad might the COVID-19 outbreak get in the United States, and what measures are needed to contain it? We reviewed statements from government health officials and surveyed infectious disease experts to forecast the coming weeks.
Andrew Pekosz is quoted.

March 16, 2020
The Baltimore Sun

In an article published Friday in the Journal of Clinical Investigation, researcher Arturo Casadevall argues that blood injections from patients who have recovered from COVID-19 might help protect at-risk people — including health care workers and family members caring for sick relatives — from falling prey to the disease

March 5, 2020
Allure

There are two types of masks used in preventing infections: surgical masks and respirator masks. It’s important to know the difference, and which situations they’re useful in.
Andrew Stanley Pekosz is quoted.

March 3, 2020
The Philadelphia Inquirer

J Roswell Gallagher took a decisive step in 1934 to tackle a measles outbreak that has relevance for how the world responds to the new coronavirus.
Arturo Casadevall is quoted.

March 3, 2020
Maryland Public Television

Andrew Pekosz is featured for the full show, hosted by Jeff Salkin, discussing the latest coronavirus/COVID-19 news.

March 3, 2020
CBS News

A taxi driver in Thailand likely caught the coronavirus from Chinese tourists who were passengers in his cab. The tourists were coughing but wearing face masks, the driver said. He still caught the virus, despite the masks.
Andrew Pekosz is featured.

March 2, 2020
NPR

As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus. This kind of test is still under development in the United States, but it has been rolled out for use in Singapore and China.
Andrew Pekosz is quoted.

February 28, 2020
The Wall Street Journal
[Opinion] 
A school physician’s approach to measles in 1934 has lessons for the coronavirus.
Arturo Casadevall wrote the article.

February 28, 2020
CBS News

As fears over the coronavirus spread, thousands of Americans are clamoring to buy face masks in an effort to protect themselves, sending prices soaring and leading manufacturers like 3M to ramp up production. However, experts say stocking up on face masks is actually misguided — and there's a much simpler thing you could be doing right now to protect yourself.
Andrew Stanley Pekosz is quoted.

February 28, 2020
NPR

As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus.
Andrew Stanley Pekosz is quoted.

February 21, 2020
The New York Times
 [Paywall]
The coronavirus that originated in China has spread fear and anxiety around the world. But while the novel virus has largely spared one vulnerable group—children—it appears to pose a particular threat to middle-aged and older adults, particularly men.
Sabra Klein is quoted.

February 10, 2020
FOX News

A type of black fungus that eats radiation was discovered inside the Chernobyl nuclear reactor.
A paper co-authored by Arturo Casadevall is cited.

February 5, 2020
Axios

There are a dozen research projects underway to try to come up with a vaccine for the Chinese coronavirus
Andrew Pekosz is quoted.

February 3, 2020
VOA News

According to recent reports, a vaccine against the new Wuhan coronavirus may start testing in as little as three months.
Andrew Pekosz is quoted.

January 31, 2020
CGTN

Professor Andrew Pekosz highlights the importance of tracking possible mutations by having virus data available earlier and warns of the dangers in mild infectious cases.

January 29, 2020
WBAL TV

This strain of coronavirus is new, unknown, and appears to be very efficient in its movement. The changing virus needs to be closely monitored in case it becomes even better at infecting humans.
Andrew Pekosz is quoted.

1/17/20
Bloomberg
 [Audio]
William Moss, Executive Director of the International Vaccine Access Center at the Johns ��ѻ��ý, discusses developing vaccine strategies for measles on the featured podcast.
The segment begins at the 10:27 mark.

01/14/20
Bloomberg
 [Video]
William Moss discusses the resurgence of measles outbreaks on “Bloomberg Markets.”

2019

12/10/19
Bloomberg
 [Video]
Andrew Pekosz, co-director of the Johns Hopkins Center of Excellence in Influenza Research and Surveillance, discusses the tracking of regional influenza outbreaks and the importance of vaccinations to avoid the infection.

11/05/19
WBUR 90.9

Research finds that measles, which kills more than 100,000 children a year around the globe, is an even more dangerous germ than previously thought. It can cause what the scientists call "immune amnesia:" Children who catch the measles can lose resistance they had built up to other illnesses.
William Moss is quoted.

11/05/19
The Scientist
 [Opinion]
Two studies present biological evidence that measles infections in unvaccinated children wipe out immune memories of other pathogens, putting the kids at risk of other deadly diseases. William Moss is quoted.

11/05/19
Newsweek

Parents who don't vaccinate their children against measles risk the virus "destroying" their immune systems and making them vulnerable to other diseases, scientists have warned. William Moss is quoted

11/05/19
Inverse

The measles virus may be even more harmful than previously thought, causing potentially deadly damage to immune memory, according to new research.
William Moss is quoted.

10/03/19
Gizmodo

Two decades ago, a rare but deadly fungal infection began killing animals and people in the U.S. and Canada. To this day, no one has figured out how it arrived there in the first place. Now a pair of scientists have put forth their own theory: Tsunamis, sparked by a massive earthquake in 1964, soaked the forests of the Pacific Northwest with water containing the fungus.
A paper co-authored by Arturo Casadevall is cited

10/02/19
BBC News

A major earthquake in Alaska in 1964 triggered tsunamis that washed ashore a deadly tropical fungus, scientists say.
Arturo Casadevall is quoted.

08/30/19
ABC 7 Chicago

There's a "reasonable chance" the United States will lose its measles elimination status in October because of ongoing measles outbreaks in New York, according to Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases.
William Moss and Paul Spiegel is quoted.

08/30/19
Science Mag

On 9 September, the Lancet Commission on Malaria Eradication, a group of 26 academics from around the globe, will publish a study recommending that the world set a 2050 target for eradication.
William Moss is quoted.

08/28/19
Science Magazine

The debate is about more than just the usefulness of bold goals in global health. The focus on eradication has skewed scientists’ and funders’ priorities, says Brian Greenwood, a malariologist at the London School of Hygiene & Tropical Medicine.
William Moss is quoted.

08/25/19
Newsweek

Texas could be hit by large measles outbreaks in which up to 400 people fall ill at a time, according to a forecast by researchers investigating low vaccine rates. Between 2003 and 2018, the number of children exempt from vaccines before attending school spiked from 23,000 to 64,000, according to existing research.
William Moss is quoted.

08/25/19
WebMD

Aging reduces the stronger immune response that women typically have to vaccination, a new study finds.
Sabra Klein, senior author of the study, is quoted.

08/21/19
The Atlantic

But new insights are at last accumulating.
Ying Zhang is quoted

08/19/19
STAT

As measles case counts have exploded around the globe this year, public health officials doggedly trying to rid the world of another disease scourge have watched the numbers rise with some concern.
William Moss is quoted.

08/16/19
Kenosha News

Bacterial drug resistance is a major public health problem that potentially affects all of us. Using accurate language is necessary to keep the public optimally informed about this important threat. Arturo Casadevall is quoted.

08/14/19
The Baltimore Sun
 [Paywall]
Bacterial drug resistance is a major public health problem that potentially affects all of us. Using accurate language is necessary to keep the public optimally informed about this important threat. Arturo Casadevall co-wrote the Op-Ed piece.

08/13/19
Star Tribune

Candida auris has become a global health threat since it was identified a decade ago, especially for patients with compromised immune systems.
Arturo Casadevall, co-author of the study, is quoted

08/13/19
Wired

Candida auris has spread rapidly around the globe, seemingly springing from nowhere and exposing the weaknesses in our defenses against new diseases.
Arturo Casadevall, co-author of a featured paper, is quoted.

07/30/19
Business Insider

A deadly, drug-resistant fungus called candida auris is spreading on a global scale and causing what the Centers for Disease Control and Prevention calls "urgent threats."
Arturo Casadevall is quoted.

07/29/19
The Baltimore Sun

Dr. Keerti V. Shah, a retired Johns Hopkins scientist who helped established the causality of cervical cancer, died of kidney failure Sunday at his home in Ponce Inlet, Florida.
A quote from a statement by the Johns ��ѻ��ý is featured.

07/29/19
Salon

Research argues Candida auris may be the first example of a new fungal disease emerging from climate change.
Arturo Casadevall is quoted.

07/25/19
Yahoo

The Centers for Disease Control and Prevention is warning about a deadly new fungal superbug called Candida auris fungus, which was first seen in a patient in 2009 in Japan. Scientists say it can be hard to identify with standard lab tests, and now a new study suggests climate change may be fueling it.
Arturo Casadevall is quoted.

07/24/19
Washington Post

Researchers in the United States and the Netherlands have a new theory: They propose that global warming may have played a key role and suggest that this may be the first example of a new fungal disease, Candida auris, emerging from climate change, according to a study published Tuesday in mBio, a journal of the American Society of Microbiology.
Arturo Casadevall is quoted.
NOTE: The study was also covered by: , , ,  and .

07/17/19
Infection Control Today

A study suggests that women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline.
Sabra Klein, study senior author, is quoted

07/12/19
The Atlantic

Researchers studying the cat-poop parasite, Toxoplasma gondii, made a breakthrough that will spare a lot of felines from research.
Isabelle Coppens is quoted.

06/04/19
The Science Times

Over the years, various experiments and researches have been put to motion in the hopes of finding a cure that can put an end to Malaria. This time, scientists have decided to use the spider gene to genetically produce a fungus that will, in turn, produce the venom that can quickly put these mosquitoes down.
Marcelo Jacobs-Lorena is quoted.

May 31, 2019
NPR

In the hope of finding a new way to fight malaria, scientists have used a spider gene to genetically engineer a fungus to produce a venom that can quickly kill mosquitoes.
Marcelo Jacobs-Lorena is quoted.

May 30, 2019
The Wall Street Journal
 [Paywall]
Journalist David Epstein says that late specialization demonstrably helped elite athletes in many sports. It can serve the rest of us well, too. In his latest book, “Range: Why Generalists Triumph in a Specialized World,” Mr. Epstein makes a well-supported and smoothly written case on behalf of breadth and late starts.
Arturo Casadevall is quoted.

May 29, 2019
MSN

Of the 35 essential oils used in a 2018 study as effective forms of treatment against Lyme disease, garlic, myrrh, thyme, cinnamon, allspice berries, cumin and eucalyptus were proven to kill off B. burgdorferi better than standard Lyme antibiotics.
Ying Zhang, lead author of the study, is quoted.

May 20, 2019
The Associated Press

The Vashon Island School District has seen a significant increase in fully immunized children. The number of kindergartners who received the required set of state-mandated vaccines jumped by 31% in the past six years, from 56% to nearly 74% in the 2017-18 school year.
William Moss is quoted.

May 14, 2019
Milwaukee Journal Sentinel

To fight the measles outbreak that has spread to 23 states, authorities must reduce vaccine exemptions and fight a tide of social media disinformation, a national expert told more than 200 students and faculty Monday at the Medical College of Wisconsin.
Diane Griffin is quoted.

May 8, 2019
The Scientist
 [Opinion]
The microbiologist has turned her attention full-time to unearthing problematic figures in papers- for free.
Arturo Casadevall is quoted.

May 8, 2019
NBC News

With measles scares happening everywhere from movie theaters to cruise ships to planes, individuals with compromised immune systems and their families are upending their daily routines to avoid getting the highly contagious disease.
William Moss is quoted.

May 7, 2019
The Baltimore Sun
 [Opinion]
State and local public health officials are urging parents to make sure their children's immunizations are up to date before the start of school.
William Moss is a co-author of the op-ed

May 1, 2019
PBS

If the U.S. loses its “measles elimination” status, it will join Venezuela as the only other country in North and South America with this distinction. Measles was declared eliminated across the Americas in 2016, but within a year, an outbreak sparked in Venezuela that has persisted up to the current day.
William Moss is interviewed.

May 1, 2019
The Washington Post

About 300,000 people a year are infected with Lyme disease through tick bites, and for up to 20 percent of them the condition persists after a course of antibiotics. But just in time for tick season, researchers are now onto a promising treatment for those sufferers.
Ying Zhang, the study’s senior author, is quoted.

April 26, 2019
Nature

The RTS,S vaccine is up to 40% effective at preventing malaria in young children.
Sabra Klein is quoted.

April 26, 2019
Contagion Live

World Health Organization (WHO) officials have announced plans for a pilot study in Malawi of a new vaccine—called RTS,S—to significantly reduce the disease in children. Experts from around the world gather at the Johns Hopkins Malaria Research Institute (JHMRI) in Baltimore, Maryland, for a scientific symposium entitled “Malaria Elimination in Africa” for the 13th World Malaria Day on April 25th.
William Moss is quoted.

April 26, 2019
Newsweek

UNICEF announced that 21.1 million children had missed their first dose of the measles vaccine every year over the last eight years.
William Moss is quoted.

April 24, 2019
NPR

Health officials are rolling out the first approved vaccine aimed at stopping a human parasite. It's for malaria — and the hopes are that one day the vaccine could save the lives of tens of thousands of children each year.
William Moss is quoted.

March 26, 2019
STAT

Some experts believed the world was ready to rid itself of measles once and for all. These days, with massive outbreaks in the Philippines and Ukraine, more than 80,000 cases in the past year in Europe, and ongoing epidemics in New York, Washington, Texas, Illinois, and California, measles does not feel like an endangered virus.
Williams Moss is quoted.

March 21, 2019
Newsweek

Scientists studying anti-vax posts on Facebook found that the movement doesn't stem from one fear, but rather a range of theories believed by people spanning demographics and the political spectrum.
William Moss is quoted

February 22, 2019
Newsweek

Japan has been undergoing its worst measles outbreak in at least a decade, and one religious order opposed to vaccinations has now apologized for its role in helping to spread the disease.
William Moss is quoted.

February 11, 2019
Palm Beach Daily News

Six health care subjects were covered at “A Woman’s Journey” presented by Johns Hopkins Medicine. The Palm Beach Daily News was one of the sponsors.
Sabra Klein was among the speakers at the 13th annual conference.

February 11, 2019
Newsweek

As Washington state deals with a measles outbreak that has caused at least 53 people—the majority of whom are unvaccinated children—to contract the potentially deadly disease, young people have asked how they can get vaccinated without their parents' knowledge. 
William Moss is quoted.

February 7, 2019
MSN

In a study published almost a year ago, scientists identified "anti-vaxx hotspots"—and the areas flagged include those where cases of measles are being reported. 
William Moss is quoted.

February 1, 2019
Newsweek

Almost 20 years after measles was eliminated in the U.S., 2019 could see the highest rates of the dangerous disease in three decades, an expert has warned.  
William Moss is quoted.

January 30, 2019
Newsweek

A 1986 essay written by the late Charlie and the Chocolate Factory author Roald Dahl about his daughter dying of measles has been shared widely online, as new outbreaks of the dangerous disease have given it fresh relevance.
William Moss is quoted.

2018

December 21, 2018
Science Trends

Recent research on baker’s yeast uncovered a new way cells slow their growth down when nutrients are running low. This information from an improbable source provides new insight into a family of uncharacterized human genes, some of which cause severe neurological disorders, epilepsy, and possible autism when mutated.
J. Marie Hardwick wrote the piece.

December 3, 2018
Science News

Political unrest and refusal to vaccinate is driving the measles surge, health experts say.
Bill Moss is quoted.

November 13, 2018
Reader's Digest

Everyone should still get their flu shots, but at least we're rolling into this year's flu season with a new weapon: a drug that stops the virus in its tracks.
Andrew Pekosz is quoted

September 28, 2018
Medical Daily

Since flu season is right around the corner, it is important to start taking preventative measures. The CDC estimates that influenza has annually resulted in between 9.2 million and 35.6 million illnesses.
Andrew Pekosz is quoted.

September 26, 2018
CNN

Researchers have rendered a population of mosquitoes in a lab sterile using the gene-editing tool CRISPR-Cas9 by homing in on a specific target in insect DNA -- the doublesex gene -- raising the possibility of eradicating disease-carrying species of the insect entirely, according to a new study
Conor McMeniman is quoted.

September 8, 2018
Consumer Reports

Last year’s season set new records both for numbers of children who died from flu and for flu-related hospitalizations. But should people get the shot now, before the flu even arrives in January and February?
Andrew Pekosz is quoted.

August 28. 2018
KJZZ 91.5 – Phoenix

The World Health Organization this week reported cases of measles have hit a record high in the European region.
Bill Moss joins the radio show and weighs in on the concerning increase in measles cases in some parts of the world.

August 21, 2018
The Baltimore Sun

Biological threats continue to evolve, even as public focus careens from one crisis to another. The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 funded the agencies that maintain a focus on biosecurity, and that act is now up for reauthorization.
Rachel Evans, a PhD student in the W. Harry Feinstone Department of Molecular Microbiology, wrote the piece.

August 20, 2018
NPR

A Disney video details many of the important measures Americans took to protect themselves from malaria, getting rid of standing water, screening windows, papering over cracks in the walls, and even weeding ponds to make it easier for fish to eat mosquito larvae.
William Moss is quoted.

August 10, 2018
STAT News

The training of new scientists has become a highly specialized endeavor that frequently emphasizes the acquisition of factual knowledge instead of skills that are essential for good scientific practice, such as critical thinking, rigorous research design, analysis, and philosophy of science.
Gundula Bosch and Arturo Casadevall wrote the article.

July 30, 2018
Everyday Health

Malaria caused by recurrent Plasmodium vivax (P. vivax) is a difficult-to-treat and life-threatening condition that affects 8.5 million people a year. On July 20th, the FDA approved a new drug to help treat this problem.
David Sullivan is quoted

July 18, 2018
Newsweek

Due to a higher presence of a lung-healing protein, men may recover quicker from cases of the flu than women according to a recent study.
Sabra Klein is quoted.

July 13, 2018
The Scientist

Worldwide, millions of animals are used for toxicity testing of compounds intended for human and environmental use. Now, toxicologists have developed software that can accurately predict the outcomes of assays.
Thomas Hartung is quoted.

July 12, 2018
One India

Zika virus could pose a far greater threat to pregnancy than recent studies of miscarriage and stillbirth in human infections have reported. This virus do not show any symptoms and thusraises concerns about the complications which are likely to arise from this condition.
Sabra Klein is quoted.

June 6, 2018
CNN

Russia has also been heavily affected by the recent outbreak of measles, with more than 800 cases reported in 2018. Children and adults who are traveling to Russia for the World Cup -- which takes place between June 14 and July 15 -- should therefore make sure that they have received two doses of the measles vaccine.
Diane Griffin is quoted.

April 8, 2018
CBC (Canada)

Neither plants nor animals, fungi are the most underappreciated kingdom of the natural world. During a billion years of evolution, they’ve become masters of survival. And yet, fungi have also been integral to the development of life on Earth. In fact, neither land plants nor terrestrial animals would exist without them. Arturo Casadevall is quoted.

March 22, 2018
The San Diego Union Tribune

One-third of Africans carry a previously unknown mutation that appears to help them resist malaria, according to an international study led by scientists from The Scripps Research Institute. If confirmed with more research, the discovery may lead to new malaria drugs, and have implications for the health of those who carry the genetic trait. Sean Prigge is quoted.